Factors influencing health status and contact with health services

Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z00-ZZB Hospital discharge: ICD-9 — V Hospital discharge: ICD-8 — Y Cause of death: ICD-10 — Z00-ZZB Cause of death: ICD-9 — V Cause of death: ICD-8 — Y 2 out of 7 registries used, show all original rules.	404180
4. Check minimum number of events None	404180
5. Include endpoints None	404180
6. Filter based on genotype QC (FinnGen only)	389014

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 1
First used in FinnGen datafreeze: DF4

NAME	Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z
HD_ICD_9	V
HD_ICD_8	Y
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z
COD_ICD_9	V
COD_ICD_8	Y
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Factors influencing health status and contact with health services based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	389014	241228	147786
Unadjusted period prevalence (%)	78.78	85.57	67.71
Median age at first event (years)	43.17	35.41	55.84

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
23066: Matched controls
115760

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

10.1

322.3

548

279

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

74.2

319.8

321

SPAT1380

SPAT

Postpartum check-up

11.0

319.8

518

241

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

319.4

6033

18163

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

10.1

319.0

543

277

SPAT1379

SPAT

Health check-up of pregnant person

7.5

312.1

641

440

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.5

309.4

2671

5857

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.3

307.7

3619

8754

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

145.9

307.7

372

N02AX02

ATC

tramadol; systemic, rectal

1.9

307.7

7589

23505

Z39.2

ICD-10 Finland

Routine postpartum follow-up

20.6

307.7

770

194

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

69.1

307.7

656

Z31.4

ICD-10 Finland

Procreative investigation and testing

28.4

307.7

401

1412

FHL

Laparoscopy and sterilization

54.9

307.7

440

Z01.0

ICD-10 Finland

Examination of eyes and vision

15.3

307.7

3069

1150

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

36.0

307.7

1503

224

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

307.7

4278

11273

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

4303

11308

DFF00

NOMESCO Finland

Pure tone audiometry

4.7

307.7

1388

1551

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

5.6

307.7

2120

2072

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

365.3

307.7

1240

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

18.7

307.7

1141

321

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

7.7

307.7

862

580

H02AB06

ATC

prednisolone; systemic

1.9

307.7

8302

26961

C07AB07

ATC

bisoprolol; oral

2.0

307.7

8513

26618

Z51.5

ICD-10 Finland

Palliative care

14.1

307.7

1077

400

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

43.7

307.7

528

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

+∞

307.7

651

Z97.4

ICD-10 Finland

Presence of external hearing-aid

355.9

307.7

688

C03CA01

ATC

furosemide; systemic

2.1

307.7

5111

13891

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

17944

69585

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

44.5

307.7

797

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

4.9

307.7

1336

1423

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

307.7

4618

11906

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

13491

51536

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

10.8

307.7

1965

989

ZXD05

NOMESCO Finland

Urgent procedure

2.1

307.7

5057

13808

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

50.4

307.7

916

Z50.1

ICD-10 Finland

Other physical therapy

24.7

307.7

693

145

Z71.8

ICD-10 Finland

Other specified counselling

3.2

307.7

5113

9411

Z01.8

ICD-10 Finland

Other specified special examinations

9.1

307.7

4003

2601

Z37.0

ICD-10 Finland

Single live birth

+∞

307.7

482

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

307.7

3706

8410

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

210.5

307.7

731

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

23.4

307.7

820

182

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

+∞

307.7

581

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

307.7

8068

22423

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

22.9

307.7

517

116

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.2

307.7

4853

12561

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

12532

41730

N06AX11

ATC

mirtazapine; oral

2.0

307.7

5643

15989

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

19.2

307.7

703

189

W78

ICPC

Pregnancy

6.5

307.7

950

755

N02AA05

ATC

oxycodone; systemic

2.9

307.7

2714

5031

S18

ICPC

Laceration/cut

1.9

307.7

7704

24291

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

11.8

307.7

969

430

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

95.4

307.7

611

Z3231

NOMESCO Finland

Registered nurse

2.4

307.7

4662

10994

N05AH04

ATC

quetiapine; oral

2.5

307.7

2989

6541

Z96.1

ICD-10 Finland

Presence of intraocular lens

12.1

307.7

2236

1014

KFD46

NOMESCO Finland

Bilateral vasectomy or ligature of vas deferens

89.2

307.7

538

Z32.1

ICD-10 Finland

Pregnancy confirmed

17.3

307.7

549

163

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

19.0

307.7

609

165

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

16.1

307.7

847

274

J01DB01

ATC

cefalexin; oral

2.1

307.7

16665

64685

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

149.5

307.7

467

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

4202

10450

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

19.9

307.7

849

222

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

56.4

307.7

1134

106

Z30.2

ICD-10 Finland

Sterilization

37.7

307.7

1271

179

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

7.5

307.7

3036

2287

Z00.0

ICD-10 Finland

General medical examination

3.2

307.7

3278

5760

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

4752

9935

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

22.9

307.7

510

114

N03AX16

ATC

[U] pregabalin

2.4

307.7

3543

8105

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.9

307.7

2034

3752

UJF32

NOMESCO Finland

Coloscopy

2.5

307.7

4086

9315

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

307.7

2686

5643

Z01.1

ICD-10 Finland

Examination of ears and hearing

7.9

307.7

2350

1646

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

307.7

5876

16808

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

95.9

307.7

1401

Z31.5

ICD-10 Finland

Genetic counselling

+∞

307.7

570

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

835.2

307.7

943

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

16.9

307.7

709

217

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

95.3

307.7

682

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

161.3

307.7

317

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

27.2

307.7

405

B01AB05

ATC

enoxaparin; parenteral

2.1

307.7

4679

12723

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

306.6

7207

23225

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

679.2

304.7

398

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

60.2

300.4

308

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

297.5

7658

25319

Z3229

NOMESCO Finland

Other healthcare associate professional

3.6

296.9

1284

1861

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

12.6

296.1

448

181

SPAT1263

SPAT

Sampling

1.8

295.5

7054

22786

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

294.6

7267

23704

RD211, ,

NOMESCO Finland

9.3

294.2

524

289

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

293.9

4071

10924

N03AX12

ATC

[U] gabapentin; oral

2.5

293.8

2353

4965

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

292.9

5391

16013

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

27.2

292.4

342

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

9.3

292.1

521

288

R53

ICD-10 Finland

Malaise and fatigue

2.1

291.2

3810

9997

A02BC05

ATC

esomeprazole; systemic

1.8

289.0

6648

21202

L28

ICPC

Limited function/disability (L)

2.5

286.8

2447

5324

AN1

Coronary angiography

3.0

286.3

1674

2966

DFF15

NOMESCO Finland

Speech audiometry

7.4

285.9

591

409

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

285.5

4113

11188

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

282.5

2677

6119

XCK10

NOMESCO Finland

Photography of fundus of eye

3.3

278.1

1369

2172

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

278.0

2867

6805

R03AC02

ATC

salbutamol; inhalant

1.7

277.6

9640

34518

M79.6

ICD-10 Finland

Pain in limb

1.8

277.0

6663

21485

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

9.8

276.2

476

248

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

274.8

4676

13482

SPAT1197

SPAT

Extensive health check-up of expecting family

5.1

274.4

789

805

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.1

271.3

1498

2560

Z04.3

ICD-10 Finland

Examination and observation following other accident

72.7

270.4

272

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

267.6

3485

9100

N05BA04

ATC

oxazepam; oral

2.0

264.4

4047

11223

ZXE00

NOMESCO Finland

One hour or less

1.8

264.0

6316

20278

SPAT1216

SPAT

Assessment of functional ability

2.5

259.9

2121

4505

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

26.6

258.7

304

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

258.2

3825

10473

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

38.6

257.7

281

M54.5

ICD-10 Finland

Low back pain

1.8

257.6

5750

18053

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

256.3

13394

52937

Y6099

ICD-8 Finland

Prenatal care and observation

+∞

252.6

323

J01MA02

ATC

ciprofloxacin; systemic

1.7

251.4

6730

22266

A28

ICPC

Limited function/disability NOS

2.3

251.3

2369

5386

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

251.1

6182

19961

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

556.3

250.0

328

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

+∞

249.5

319

H25.1

ICD-10 Finland

Senile nuclear cataract

1.9

247.4

3988

11237

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

9.3

247.3

440

242

WX307

NOMESCO Finland

Obstetric epidural analgesia

9.5

246.9

434

234

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

245.8

1674

3231

N05CF01

ATC

zopiclone; oral

1.8

244.4

5329

16568

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

242.1

1889

3917

MA3AE

NOMESCO Finland

Combined first trimester screening

535.7

240.6

316

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

239.5

4497

13324

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

6.0

238.7

585

502

R51.80

ICD-10 Finland

Headache

2.4

236.0

2153

4815

R42

ICD-10 Finland

Dizziness and giddiness

2.0

234.8

3323

8918

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

234.3

9665

35688

B01AC04

ATC

clopidogrel; oral

2.2

234.1

2465

5877

ZX120

NOMESCO Finland

Intravenous

3.0

233.8

1302

2232

J01CA04

ATC

amoxicillin; systemic

1.7

232.6

16261

68322

XQ800

NOMESCO Finland

Prick test

3.9

232.4

890

1172

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

230.5

5823

18860

SPAT1301

SPAT

No procedures

1.8

230.4

4953

15292

SPAT1153

SPAT

Removal of sutures

1.8

230.2

4824

14776

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

228.7

2131

4809

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

228.5

6791

23001

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

227.9

6206

20518

N06AX21

ATC

duloxetine; oral

2.7

226.6

1552

3001

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

225.3

1861

3965

L03

ICPC

Low back symptom/complaint

1.9

222.8

4086

11981

G47.3

ICD-10 Finland

Sleep apnoea

1.9

221.8

3882

11206

O80.0

ICD-10 Finland

Spontaneous vertex delivery

2.7

221.2

1480

2824

R5120

NOMESCO Finland

Preparation of an aid

10.0

220.6

376

192

XF402

NOMESCO Finland

ECG with work load test

2.8

219.1

1445

2735

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

218.2

2255

5325

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

217.5

2214

5193

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

7.1

216.1

460

331

A04

ICPC

Weakness/tiredness general

2.3

215.8

2170

5062

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

215.4

2898

7613

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

215.2

5401

17402

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

214.2

3795

10987

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

214.0

4168

12442

-1, ,

NOMESCO Finland

1.7

213.4

5685

18620

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

212.7

3562

10117

R4110

NOMESCO Finland

Physiotherapy

1.8

211.8

4301

13003

J01AA02

ATC

doxycycline; systemic

1.6

211.8

14483

59727

127

Kela drug reimbursment

Transplant complication

95.8

211.5

208

R5140

NOMESCO Finland

Monitoring the use of the aid

2.5

210.0

1757

3762

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.1

210.0

1152

1954

L17

ICPC

Foot/toe symptom/complaint

1.8

210.0

4321

13114

Z3226

NOMESCO Finland

Physiotherapist

2.1

209.9

2747

7135

I49.5

ICD-10 Finland

Sick sinus syndrome

6.4

206.7

480

386

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

206.4

9386

35138

MAX99

NOMESCO Finland

Assistance to normal delivery

6.8

205.2

453

342

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

205.1

1959

4462

OAA11, ,

SPAT

10.7

204.7

336

160

XF404

NOMESCO Finland

Ambulatory ECG

3.0

203.6

1185

2084

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

203.4

2936

7904

R50.9

ICD-10 Finland

Fever, unspecified

2.1

203.2

2375

5896

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

203.0

2711

7090

ZXA00

NOMESCO Finland

Right side

1.8

202.9

4122

12445

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

202.2

4666

14636

Z3232

NOMESCO Finland

Midwife

7.6

202.0

408

273

SPAT1254

SPAT

Administration of medicine

2.2

201.8

2320

5720

KMAK, ,

NOMESCO Finland

1.6

200.9

8755

32386

M25.5

ICD-10 Finland

Pain in joint

1.7

200.1

4862

15473

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

198.9

8059

29285

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

198.7

12171

48603

B01AA03

ATC

warfarin; systemic

1.9

198.5

3149

8761

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

17.9

198.4

261

H26.4

ICD-10 Finland

After-cataract

2.8

198.2

1245

2289

N06AX16

ATC

venlafaxine; oral

2.3

197.6

1968

4563

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.2

197.3

1016

1654

UKC02

NOMESCO Finland

Cystoscopy

2.1

196.9

2521

6483

K02.1

ICD-10 Finland

Caries of dentine

1.5

196.8

10714

41636

ZXA05

NOMESCO Finland

Left side

1.8

196.2

3837

11434

A10AB05

ATC

insulin aspart; parenteral

3.0

196.1

1127

1966

A10AE04

ATC

insulin glargine; parenteral

2.6

193.1

1435

2891

J01MA12

ATC

levofloxacin; systemic

2.0

192.1

2877

7837

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

190.8

2423

6207

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

190.7

4844

15582

WX002

NOMESCO Finland

Sedation and analgesia

2.0

190.6

2795

7555

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

190.3

3736

11136

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

190.2

10377

40236

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.9

190.1

725

950

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

189.1

1149

2071

O99.80

ICD-10 Finland

The fear of childbirth

16.0

188.3

258

Z00.8

ICD-10 Finland

Other general examinations

3.0

187.6

1055

1815

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.8

187.2

1193

2210

Z2221

NOMESCO Finland

Medical doctor

1.8

186.9

4104

12650

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

186.4

1347

2673

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

186.4

3852

11657

N06AB10

ATC

escitalopram; oral

1.9

184.5

3106

8801

P01AB01

ATC

metronidazole; oral, rectal

1.6

183.5

5990

20556

I44.2

ICD-10 Finland

Atrioventricular block, complete

7.2

182.3

382

269

WZC30

NOMESCO Finland

Teaching

2.1

181.5

2216

5585

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

180.6

1426

2961

WX290

NOMESCO Finland

Other blockage of nerve

1.5

180.1

8343

31075

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

179.9

2551

6803

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.4

176.7

1470

3131

SPAT1262

SPAT

Handing over of treatment supplies

2.0

176.5

2556

6866

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

38.9

176.4

192

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.8

176.0

1139

2127

SFA10

NOMESCO Finland

One-surface restoration

1.5

175.8

9662

37299

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

43.2

175.6

188

C10AA01

ATC

simvastatin; oral

1.6

175.6

6722

23931

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

175.5

2978

8449

J01DA01

ATC

[U] cefalexin

1.5

175.5

11438

45772

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

175.1

6356

22341

SPAT1310

SPAT

Counselling related to known health issue

1.7

174.1

4916

16216

A02BC03

ATC

lansoprazole; oral

1.7

173.2

4421

14188

C09AA05

ATC

ramipril; oral

1.7

172.4

4017

12564

WX320

NOMESCO Finland

Spinalanesthesy

1.8

172.4

3434

10252

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

172.3

1834

4366

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

171.8

856

1362

J01FF01

ATC

clindamycin; systemic

1.7

171.3

4313

13785

R02

ICPC

Shortness of breath/dyspnoea

2.3

170.4

1710

3969

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

40.2

169.1

183

N06AB04

ATC

citalopram; systemic

1.8

168.8

3089

8975

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

166.1

2055

5197

E0000UV, ,

ATC

1.6

164.6

6856

24806

H25.8

ICD-10 Finland

Other senile cataract

2.4

164.2

1401

3018

XMA22

NOMESCO Finland

General examination of pregnant woman

9.9

163.0

278

142

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

163.0

3749

11662

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

162.7

2514

6897

C01DA14

ATC

isosorbide mononitrate; oral

1.9

162.5

2513

6896

SFA20

NOMESCO Finland

Two-surface restoration

1.5

161.7

10277

40647

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

161.6

2898

8356

ZY010

NOMESCO Finland

Hospital outpatient

3.6

161.4

696

1001

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

161.2

1979

4988

Z2446

NOMESCO Finland

Social worker

2.9

160.7

966

1728

ZXA10

NOMESCO Finland

Bilateral

1.9

160.3

2630

7362

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

159.3

1471

3286

T90

ICPC

Diabetes non-insulin dependent

1.7

158.0

3519

10836

R01AD09

ATC

mometasone; nasal

1.5

157.7

7382

27350

A02BC01

ATC

omeprazole; systemic

1.7

157.5

4166

13458

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.0

157.4

578

734

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.6

156.9

662

937

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

8.4

156.8

296

179

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

156.3

1363

2965

C08CA01

ATC

amlodipine; oral

1.6

155.3

6067

21574

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

154.7

1213

2505

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

7.4

154.4

317

217

OAA12, ,

SPAT

14.2

154.0

221

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

153.8

4421

14585

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

18.9

153.4

198

A29

ICPC

General symptom/complaint other

2.2

153.0

1708

4140

G04CA02

ATC

tamsulosin; oral

1.6

152.6

4415

14586

C10AA05

ATC

atorvastatin; oral

1.5

152.6

6622

24092

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

152.0

2744

7917

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.9

152.0

581

762

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

151.5

1405

3143

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

150.3

3089

9276

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

36.3

149.8

165

A06AD11

ATC

lactulose; oral

1.9

149.5

2284

6231

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

148.9

1577

3739

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

148.7

872

1536

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

8.2

148.1

284

176

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

147.5

2109

5619

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

147.1

2913

8645

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.9

146.9

363

314

DAX08

NOMESCO Finland

Fitting of hearing aid

3.6

146.2

629

903

R06AE07

ATC

cetirizine; oral

1.5

146.2

7090

26365

R05

ICPC

Cough

1.7

146.0

3402

10588

OAA10, ,

SPAT

11.0

145.9

235

108

Z34

ICD-10 Finland

Supervision of normal pregnancy

17.9

145.3

191

M03BX02

ATC

tizanidine; oral

1.5

145.2

10711

43285

Z01.2

ICD-10 Finland

Dental examination

1.5

144.2

7458

28086

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

143.7

8326

32081

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

141.8

1051

2108

M48.0

ICD-10 Finland

Spinal stenosis

2.1

141.5

1622

3970

Y0599

ICD-8 Finland

Investigation of digestive system

+∞

141.3

181

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

141.0

868

1573

XCK00

NOMESCO Finland

Perimetry

3.1

140.7

751

1248

W85

ICPC

Gestational diabetes

16.6

140.7

190

R11

ICD-10 Finland

Nausea and vomiting

2.5

140.7

1134

2372

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.8

140.6

549

732

N03AX09

ATC

lamotrigine; oral

3.5

140.2

607

875

Z2445

NOMESCO Finland

Psychologist

3.9

140.2

539

710

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

139.8

1118

2330

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

7.8

139.6

276

179

XA402

NOMESCO Finland

ENMG

8.1

139.6

269

168

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

138.5

3023

9222

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

138.3

2357

6662

Z01.9

ICD-10 Finland

Special examination, unspecified

3.1

138.0

741

1236

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

137.8

1219

2666

SPAT1097

SPAT

Recording of ECG

2.0

137.6

1928

5094

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

136.9

2439

6992

G44.2

ICD-10 Finland

Tension-type headache

2.0

136.9

1743

4444

SPAT1252

SPAT

Overall medication plan or its review

2.8

136.8

843

1528

B03XA02

ATC

darbepoetin alfa; parenteral

8.5

136.7

256

153

N05AH03

ATC

olanzapine; systemic

2.7

136.3

940

1814

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

135.9

1510

3648

N06AB06

ATC

sertraline; oral

2.1

135.8

1575

3871

L04AA06

ATC

mycophenolic acid; systemic

10.7

135.8

222

105

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

135.4

3390

10743

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

134.9

1303

2965

XKD00

NOMESCO Finland

Uroflowmetry

1.8

134.7

2549

7446

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

134.6

3254

10211

J02AC01

ATC

fluconazole; systemic

1.6

133.7

5000

17501

A01

ICPC

Pain general/multiple sites

2.4

133.2

1159

2514

TK800

NOMESCO Finland

Hemodialysis

7.5

132.8

271

184

SPAT1229

SPAT

Assessment of need for aid

2.7

132.2

916

1772

R07.3

ICD-10 Finland

Other chest pain

2.2

131.6

1406

3340

GD1LA

NOMESCO Finland

23.6

131.5

159

L13

ICPC

Hip symptom/complaint

1.9

131.3

2236

6312

XQ802

NOMESCO Finland

Epicutan test

4.8

131.0

395

421

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

130.6

785

1402

A10BA02

ATC

metformin; oral

1.6

130.3

4454

15254

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

129.8

490

636

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

129.8

1882

5029

EBA00

NOMESCO Finland

Extraction of tooth

1.5

129.6

6134

22570

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

129.5

1849

4914

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.6

129.2

543

766

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

129.1

1813

4789

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

129.0

881

1691

Z49.1

ICD-10 Finland

Extracorporeal dialysis

+∞

128.8

165

M01AH05

ATC

etoricoxib; oral

1.4

128.5

10668

43681

Z51.6

ICD-10 Finland

Desensitization to allergens

52.0

128.5

134

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

127.5

3700

12167

S06.0

ICD-10 Finland

Concussion

2.0

127.2

1628

4155

T89

ICPC

Diabetes insulin dependent

3.5

127.0

558

813

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

126.2

1504

3734

A46

ICD-10 Finland

Erysipelas

1.8

125.7

2233

6386

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.2

125.7

622

984

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

125.7

1456

3574

L08

ICPC

Shoulder symptom/complaint

1.7

125.4

3093

9744

R13

ICD-10 Finland

Dysphagia

2.7

125.1

866

1674

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.9

124.8

740

1311

L15

ICPC

Knee symptom/complaint

1.7

124.0

3334

10744

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.6

124.0

876

1712

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.6

123.7

892

1762

SFA30

NOMESCO Finland

Three-surface restoration

1.5

122.7

6893

26187

A10AE05

ATC

insulin detemir; parenteral

2.9

122.4

740

1326

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

122.4

1501

3767

R05

ICD-10 Finland

Cough

1.7

122.3

3021

9516

XCH00

NOMESCO Finland

Eye pressure measurement

3.6

122.1

519

738

R55

ICD-10 Finland

Syncope and collapse

2.0

121.5

1585

4072

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

121.3

4187

14342

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

5.4

121.1

325

308

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.2

120.8

283

230

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

120.5

1016

2170

207

Kela drug reimbursment

Chronic arrhythmias

1.8

120.3

2115

6024

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

120.2

1194

2748

J01FA10

ATC

azithromycin; systemic

1.4

119.5

10118

41377

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

119.1

1245

2928

A98

ICPC

Health maint/preventive medicine

1.6

118.3

20042

93058

M01AE02

ATC

naproxen; oral, rectal

1.4

118.1

9944

40593

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

117.8

2097

5994

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

117.7

418

516

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

117.0

6707

25529

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

116.6

1646

4350

SPAT1260

SPAT

Consultation of another employee

1.8

116.5

2432

7298

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

116.4

12772

54499

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

116.3

847

1681

Angiography of the heart and coronary arteries

2.6

116.3

826

1618

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

115.6

2180

6343

M01AB05

ATC

diclofenac; systemic, rectal

1.4

115.2

11862

50033

W84

ICPC

Pregnancy high risk

16.9

115.0

154

R60.0

ICD-10 Finland

Localized oedema

2.0

114.8

1565

4084

Z94.0

ICD-10 Finland

Kidney transplant status

+∞

114.8

147

R03BB04

ATC

tiotropium bromide; inhalant

2.0

114.3

1471

3757

A11CC03

ATC

alfacalcidol; systemic

5.7

114.1

291

261

P20

ICPC

Memory disturbance

1.9

113.7

1652

4410

SPAT1312

SPAT

General health counselling

1.5

113.4

4886

17542

SPAT1240

SPAT

Therapeutic discussion

2.1

113.4

1413

3565

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

113.3

623

1054

WX892

NOMESCO Finland

Monitored bed care

2.3

113.0

1024

2261

Z75.5

ICD-10 Finland

Holiday relief care

192.6

112.4

153

C07AA05

ATC

propranolol; systemic

1.7

112.3

2885

9167

R74

ICPC

Upper respiratory infection acute

1.5

112.2

4855

17442

J01FA06

ATC

roxithromycin; oral

1.4

112.0

6342

24039

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

112.0

1094

2498

WX872

NOMESCO Finland

Intensive care

2.9

111.8

671

1197

N03AG01

ATC

valproic acid; systemic, rectal

2.6

111.7

814

1616

A10AC01

ATC

insulin (human); parenteral

2.2

111.2

1113

2568

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

111.2

945

2025

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

111.1

5451

20085

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

111.0

1327

3294

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.3

110.8

299

285

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

110.4

1050

2369

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

110.2

3123

10173

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

110.0

2890

9233

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

109.7

2626

8182

R31

ICD-10 Finland

Unspecified haematuria

2.0

109.7

1550

4095

W90

ICPC

Uncompl labour/delivery livebirth

6.5

109.7

248

193

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

109.4

18040

82197

ZYC01

NOMESCO Finland

Remote contact by phone

2.7

109.2

749

1440

M01AC06

ATC

meloxicam; systemic, rectal

1.5

108.9

5518

20450

X58

ICD-10 Finland

Exposure to other specified factors

1.7

108.6

2265

6786

N30.0

ICD-10 Finland

Acute cystitis

1.8

108.5

1854

5224

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.5

108.5

473

685

N17

ICPC

Vertigo/dizziness

2.0

108.5

1513

3978

R21

ICPC

Throat symptom/complaint

1.6

108.0

3037

9870

J01EA01

ATC

trimethoprim; systemic

1.6

107.9

3327

11061

AS4

Physiological pacemaker insertion DDD (R)

19.0

107.9

139

D07AC01

ATC

betamethasone; topical

1.5

107.8

5728

21417

M79.1

ICD-10 Finland

Myalgia

1.8

107.7

1902

5416

L12

ICPC

Hand/finger symptom/complaint

1.7

107.6

2293

6912

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

107.6

1565

4176

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

107.3

1201

2903

P06

ICPC

Sleep disturbance

1.9

107.1

1653

4502

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

106.9

2042

5958

J01MA14

ATC

moxifloxacin; systemic

2.1

106.8

1240

3042

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

106.7

3530

11932

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

13.1

106.6

158

8221

FHL

Sterilization of the laparotomy pathway

9.1

106.5

190

105

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

106.2

1104

2588

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

105.7

1156

2767

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

105.7

788

1582

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.9

105.6

310

322

N05CF02

ATC

zolpidem; oral

1.7

105.4

2388

7324

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

104.8

979

2190

K78

ICPC

Atrial fibrillation/flutter

2.3

104.5

947

2090

H13

ICPC

Plugged feeling ear

1.6

104.4

2757

8811

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.0

104.4

571

963

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.9

104.3

395

514

R33

ICD-10 Finland

Retention of urine

2.1

104.3

1227

3025

O80.8

ICD-10 Finland

Other single spontaneous delivery

6.5

104.1

237

186

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

104.0

1712

4764

C03DA01

ATC

spironolactone; oral

1.9

103.7

1639

4499

B01AB10

ATC

tinzaparin; parenteral

2.1

103.6

1204

2954

WX402

NOMESCO Finland

General anaesthesia

1.6

103.5

3020

9896

SPAT1325

SPAT

Vaccination

1.5

103.5

4989

18276

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

103.4

2366

7273

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

103.3

1226

3032

J01CA08

ATC

pivmecillinam; oral

1.5

103.2

4684

16950

N06AA09

ATC

amitriptyline; systemic

2.2

102.9

1121

2679

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

4.6

102.8

324

360

A04AA01

ATC

ondansetron; systemic, rectal

2.4

102.8

885

1907

JN4AD

NOMESCO Finland

Body CT examination

2.1

102.8

1260

3156

S01ED51

ATC

timolol, combinations; ophthalmic

2.3

102.7

979

2210

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

102.6

1737

4877

L01

ICPC

Neck symptom/complaint

1.8

102.5

1974

5771

N02BF01

ATC

gabapentin; oral

2.3

102.4

967

2174

P03

ICPC

Feeling depressed

2.0

102.2

1321

3376

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

101.9

1788

5077

JN4BD

NOMESCO Finland

Extensive body CT

2.0

101.8

1329

3409

H91.1

ICD-10 Finland

Presbycusis

2.4

101.7

830

1743

D11

ICPC

Diarrhoea

1.9

101.5

1585

4332

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.4

101.2

461

689

P29

ICPC

Psychological sympt/compl other

2.3

101.2

933

2075

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

101.0

653

1215

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

228.3

100.7

136

N05BA01

ATC

diazepam; systemic, rectal

1.8

100.7

1876

5428

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

100.3

1485

3985

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.1

100.1

356

440

A02BA02

ATC

ranitidine; systemic

1.6

99.9

2809

9113

Y0399

ICD-8 Finland

Investigation of circulatory system

+∞

99.9

128

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

81.4

99.9

145

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

99.8

675

1287

N06AB03

ATC

fluoxetine; oral

1.9

99.6

1620

4487

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.0

99.6

561

963

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

99.1

3356

11385

D01

ICPC

Abdominal pain/cramps general

1.9

98.9

1496

4043

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

98.6

640

1193

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.3

98.5

475

738

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.2

98.5

988

2280

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

98.3

126

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.2

98.3

342

415

TMA00

NOMESCO Finland

Episiotomy

41.1

98.3

106

SPAT1043

SPAT

Audiometry

2.0

98.3

1293

3325

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

97.9

3803

13300

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

2.6

97.8

702

1382

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

97.7

1245

3163

UDC00

NOMESCO Finland

Ear microscopy

2.2

97.7

982

2268

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

97.3

1271

3259

R52.9

ICD-10 Finland

Pain, unspecified

2.0

97.2

1249

3183

A03

ICPC

Fever

1.7

96.7

2502

7941

M01AX05

ATC

glucosamine; oral

1.7

96.5

2437

7686

R03DC03

ATC

montelukast; oral

1.7

95.4

2197

6758

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

95.3

1287

3340

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

95.3

1767

5101

S97

ICPC

Chronic ulcer skin

2.5

95.2

718

1450

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

95.1

3253

11053

M04AA01

ATC

allopurinol; systemic

1.7

95.0

2010

6035

Z31.6

ICD-10 Finland

General counselling and advice on procreation

18.6

94.2

122

P01

ICPC

Feeling anxious/nervous/tense

1.8

94.2

1620

4567

S29

ICPC

Skin symptom/complaint other

1.6

94.1

2587

8338

SPAT1234

SPAT

Support of social functional capacity

2.7

93.9

634

1208

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

93.8

678

1339

H02

ICPC

Hearing complaint

1.8

93.8

1730

4985

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.0

93.3

516

876

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

92.9

1107

2740

C10AX09

ATC

ezetimibe; oral

1.7

92.8

2128

6535

B01AF02

ATC

apixaban; oral

1.9

92.7

1549

4325

G04BD12

ATC

mirabegron; oral

1.9

92.7

1374

3685

R52.2

ICD-10 Finland

Other chronic pain

3.4

92.5

416

616

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

92.4

6406

24997

L04AD02

ATC

tacrolimus; systemic

95.2

92.3

132

R01AD08

ATC

fluticasone; nasal

1.5

92.1

4279

15509

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

109.3

92.0

130

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

91.9

808

1757

J05AB01

ATC

aciclovir; systemic

1.6

91.9

2974

9969

137

Kela drug reimbursment

Uraemia requiring dialysis

20.2

91.8

116

Z01.7

ICD-10 Finland

Laboratory examination

1.7

91.8

2003

6065

I50.0

ICD-10 Finland

Congestive heart failure

2.1

91.7

1079

2657

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

91.5

721

1488

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

91.3

903

2070

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

91.0

823

1813

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.8

90.9

227

199

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

90.8

853

1912

XA800

NOMESCO Finland

Neuropsychological investigation

2.8

90.7

559

1012

Y4300

ICD-8 Finland

Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)

+∞

90.5

116

Y0499

ICD-8 Finland

Investigation of respiratory system

+∞

90.5

116

Z49.0

ICD-10 Finland

Preparatory care for dialysis

+∞

90.5

116

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

90.4

1373

3713

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

90.3

572

1052

R5110, ,

SPAT

2.5

90.2

701

1437

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

89.9

1029

2506

U02

ICPC

Urinary frequency/urgency

1.8

89.9

1531

4300

B05DA

ATC

Isotonic solutions

35.6

89.6

N02BF02

ATC

pregabalin; oral

2.5

89.4

665

1333

A11

ICPC

Chest pain NOS

2.1

89.2

1018

2477

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

89.0

895

2066

Z71.9

ICD-10 Finland

Counselling, unspecified

2.3

89.0

864

1965

R96

ICPC

Asthma

2.0

88.7

1117

2823

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

88.7

713

1486

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.4

88.6

716

1496

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

22.0

88.5

109

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

26.2

88.3

104

O81.4

ICD-10 Finland

Vacuum extractor delivery

4.8

88.0

262

276

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

88.0

1251

3305

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

88.0

924

2173

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

88.0

835

1880

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

87.8

1034

2547

114

Kela drug reimbursment

Glaucoma

2.0

87.8

1130

2880

P76

ICPC

Depressive disorder

2.3

87.6

809

1799

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

87.5

4495

16591

C07AB02

ATC

metoprolol; systemic

1.5

87.3

2999

10181

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

86.9

1473

4130

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

86.9

2978

10104

A12AA04

ATC

calcium carbonate; oral

6.9

86.7

187

137

SPAT1255

SPAT

Intravenous administration of medicine

2.3

86.6

836

1896

M54.2

ICD-10 Finland

Cervicalgia

2.1

85.9

996

2438

R5599

NOMESCO Finland

Other rehabilitation service

4.0

85.9

319

409

A10BH01

ATC

sitagliptin; oral

2.0

85.7

1208

3181

SPAT1053

SPAT

Memory test

1.8

85.5

1689

4964

A10AB04

ATC

insulin lispro; parenteral

3.4

85.4

390

584

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

85.3

1041

2599

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

85.3

1524

4344

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

85.3

523

944

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

85.1

2031

6298

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

85.1

989

2423

I20.09

ICD-10 Finland

Unstable angina

2.3

85.0

760

1665

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

85.0

499

878

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

84.7

1227

3263

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

192.7

84.6

115

N03AE01

ATC

clonazepam; systemic

2.4

84.2

699

1479

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.7

84.2

346

480

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

13.5

84.2

123

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

119.0

84.1

118

MAA00

NOMESCO Finland

Amniocentesis

27.4

84.1

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

84.1

692

1458

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

83.9

905

2151

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

83.8

914

2183

SPAT1211

SPAT

Application of soft bandage

2.0

83.5

1157

3028

R4110, ,

SPAT

2.1

83.4

962

2350

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

7.8

83.3

164

106

M01AH01

ATC

celecoxib; oral

1.6

83.2

2354

7625

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

83.2

737

1608

Z50.0

ICD-10 Finland

Cardiac rehabilitation

549.4

83.1

109

H03AA01

ATC

levothyroxine sodium; systemic

1.5

82.7

2816

9531

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.5

82.7

356

511

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

+∞

82.7

106

R4190

NOMESCO Finland

Nutritional therapy

3.1

82.7

425

689

WW500

NOMESCO Finland

Blood transfusion

3.0

82.5

445

744

G04CA01

ATC

alfuzosin; oral

1.6

82.3

2156

6849

Z39.1

ICD-10 Finland

Care and examination of lactating mother

33.1

82.2

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

5.6

82.1

211

191

N06AX12

ATC

bupropion; oral

2.1

82.1

926

2241

R03BA05

ATC

fluticasone; inhalant

1.6

82.1

2620

8736

N01

ICPC

Headache

1.8

82.1

1527

4406

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

82.1

1511

4346

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.3

82.0

730

1596

Y0609

ICD-8 Finland

Examination of the urinary and genital organs, Genital organs

+∞

81.9

105

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

81.9

1336

3698

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.2

81.7

807

1848

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.7

81.4

537

1010

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

81.2

5840

22827

W19

ICD-10 Finland

Unspecified fall

1.8

81.0

1432

4066

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

81.0

1325

3670

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.3

81.0

275

327

O02.1

ICD-10 Finland

Missed abortion

4.3

80.7

270

317

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

80.5

4093

15046

N06AX26

ATC

vortioxetine; oral

2.1

80.5

928

2266

I44.1

ICD-10 Finland

Atrioventricular block, second degree

4.8

80.2

237

248

R1250

NOMESCO Finland

Evaluation of functional capability

4.5

80.1

253

282

H02AB04

ATC

methylprednisolone; systemic

1.7

79.8

1919

5959

O82.0

ICD-10 Finland

Delivery by elective caesarean section

5.2

79.7

218

211

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.8

79.7

312

417

L29

ICPC

Musculoskeletal sympt/complt other

2.0

79.7

985

2471

V220A

ICD-9 Finland

Normal pregnancy, Supervision of normal first pregnancy

+∞

79.6

102

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

18.5

79.4

103

D07AC13

ATC

mometasone; topical

1.4

79.4

4457

16680

K30

ICD-10 Finland

Functional dyspepsia

1.8

79.4

1345

3767

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

79.4

461

806

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

79.4

1051

2705

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

34.1

79.0

E000001, ,

ATC

1.5

79.0

2972

10277

S01BC05

ATC

ketorolac; ophthalmic

2.7

78.9

524

989

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

78.8

663

1412

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

78.6

781

1793

U04

ICPC

Incontinence urine

2.6

78.6

548

1062

S01EE01

ATC

latanoprost; ophthalmic

2.3

78.5

743

1670

RF410, ,

NOMESCO Finland

9.9

78.1

133

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.8

77.9

1360

3845

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

77.9

1127

2994

N05AX08

ATC

risperidone; systemic

1.9

77.8

1251

3444

SDA03

NOMESCO Finland

Periodontal treatment

1.4

77.7

6200

24608

H29

ICPC

Ear symptom/complaint other

1.8

77.7

1460

4224

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.7

77.6

526

1004

N05AX12

ATC

aripiprazole; systemic

2.7

77.4

528

1011

N05BA12

ATC

alprazolam; oral

1.9

77.4

1283

3568

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

76.8

955

2400

R01AD12

ATC

fluticasone furoate; nasal

1.4

76.8

4642

17590

M01AX17

ATC

nimesulide; oral

1.5

76.7

3374

12046

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

76.6

321

452

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

76.5

1081

2847

M02AA07

ATC

piroxicam; topical

1.4

76.4

5488

21409

H01

ICPC

Ear pain/earache

1.8

76.3

1480

4321

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

76.3

636

1348

B05DB

ATC

Hypertonic solutions

30.9

75.8

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

75.8

621

1306

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

75.7

743

1697

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

75.4

939

2361

Z72.1

ICD-10 Finland

Alcohol use

6.7

75.4

166

125

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.7

75.1

489

913

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

75.0

837

2017

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

74.9

1299

3665

O48

ICD-10 Finland

Prolonged pregnancy

6.3

74.8

172

137

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.8

74.7

465

847

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

74.5

1029

2688

A99

ICPC

Disease/condition unspecnature/site

1.9

74.2

1188

3265

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

74.1

904

2256

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

73.9

361

566

SPAT1196

SPAT

Monitoring of normal pregnancy

4.3

73.9

248

292

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.4

73.8

332

492

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

89.1

73.8

106

AN4

Balloon angioplasty and drug eluding stent

3.1

73.5

381

621

R29

ICPC

Respiratory symptom/complaint other

2.1

73.4

829

2007

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

73.3

298

410

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.3

73.3

243

283

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

10.3

73.2

122

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013512) EKG study

5320

15318

1.97

320.50

3.9

2.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2682

5803

2.49

319.87

2.8

1.7

23.14

24.70

4.78

2319

4888

(3020779) Urea [Moles/volume] in Serum or Plasma

1971

3651

2.87

313.77

8.7

3.3

9.88

9.13

mmol/l

3.74

1882

3423

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4265

11409

2.07

312.39

1.8

1.4

1.23

1.18

mg/l

0.32

3179

8646

(3023103) Potassium [Moles/volume] in Serum or Plasma

18830

77292

2.21

307.65

17.9

9.4

3.98

3.97

mmol/l

4.80

18306

74420

(3006315) Basophils [#/volume] in Blood

9613

29395

2.10

307.65

6.3

4.7

0.04

e9/l

0.32

8436

24600

(3018095) Leukocytes [#/volume] in Urine

6651

19619

1.99

307.65

4.0

2.7

95.11

82.51

e6/l

0.39

4865

12818

(46235355) HIV 1 and 2 tests - Meaningful Use set

3864

9169

2.34

307.65

2.0

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14342

48841

2.25

307.65

8.0

5.0

79.20

76.34

u/l

7.60

13620

45427

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3214

7058

2.49

307.65

1.9

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8693

25568

2.13

307.65

2.7

2.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7328

21175

2.08

307.65

3.8

2.5

56.06

59.98

ng/l

0.16

5131

12829

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7359

22602

1.93

307.65

2.3

1.9

75.20

75.35

nmol/l

0.15

6642

20401

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

17167

70585

1.86

307.65

14.2

7.9

83.33

84.66

ml/min/173m2

10.56

14311

54580

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7352

22033

1.99

307.65

2.0

1.7

94.37

95.17

pmol/l

0.64

4005

11190

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3081

6161

2.74

307.65

1.7

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

9080

27692

2.06

307.65

6.8

5.1

8.74

8.61

3.01

8574

25771

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

341

49.61

307.65

1.5

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8124

23579

2.13

307.65

5.4

3.4

35.61

36.18

g/l

12.87

7582

21601

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

614

302

10.46

307.65

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1855

3083

3.20

307.65

1.8

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9250

25754

2.34

307.65

7.7

4.2

1.21

mmol/l

7.24

7953

21091

(3022096) Basophils/100 leukocytes in Blood

8772

26464

2.07

307.65

6.5

4.9

0.66

0.67

1.44

8268

24522

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8407

23959

2.20

307.65

6.9

4.2

1.21

mmol/l

2.20

7715

21690

(3013826) Glucose [Moles/volume] in Serum or Plasma

11204

34170

2.26

307.65

5.3

3.3

6.76

6.71

mmol/l

1.34

10529

31535

(3022217) INR in Platelet poor plasma by Coagulation assay

8935

24683

2.33

307.65

15.9

10.1

1.29

1.23

inr

1.85

2621

6800

(3019550) Sodium [Moles/volume] in Serum or Plasma

18783

76855

2.22

307.65

17.8

9.3

139.60

139.85

mmol/l

33.82

18297

74184

(3023368) Bacteria identified in Blood by Culture

5470

13626

2.33

307.65

4.6

3.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6039

18119

1.91

307.65

3.5

2.6

2.35

2.36

mmol/l

4.17

5346

16018

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7923

24088

1.99

307.65

2.9

2.1

144.36

132.19

ug/l

1.99

7315

22406

(3001604) Monocytes [#/volume] in Blood

9599

29356

2.10

307.65

6.3

4.7

0.60

0.59

e9/l

1.54

8429

24598

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2740

5628

2.64

307.65

7.0

3.1

1.05

1.01

mmol/l

7.28

2548

5198

(3031040) Bacteria [#/volume] in Urine by Automated count

11895

38343

2.15

307.65

4.4

3.1

1601.19

938.36

e6/l

0.55

167

914

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5371

12816

2.44

307.65

3.2

2.2

1646.07

1260.67

ng/l

5.41

4535

10687

(3002582) Erythrocytes [#/volume] in Urine

5811

16542

2.02

307.65

3.5

2.4

118.12

102.54

e6/l

0.21

4552

11721

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6071

16298

2.18

307.65

2.7

2.0

71.66

63.54

u/l

0.27

5655

14971

(3026008) Bacteria identified in Urine by Culture

5196

13838

2.14

307.65

3.1

2.4

—

(3013115) Eosinophils [#/volume] in Blood

9929

30492

2.11

307.65

6.6

4.9

0.20

e9/l

0.07

8820

26114

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9854

28378

2.30

307.65

6.6

4.2

11.91

12.44

umol/l

2.34

9387

26664

(40760892) CBC W Ordered Manual Differential panel - Blood

9064

27489

2.08

307.65

6.8

5.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3285

7157

2.52

307.65

3.9

2.4

0.82

0.83

mmol/l

6.09

3095

6665

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13636

50418

1.87

307.65

3.7

3.1

14.80

14.76

pmol/l

1.01

12416

45254

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2857

6252

2.48

307.65

2.7

1.7

2.30

2.36

g/l

5.60

2654

5718

(3019198) Lymphocytes [#/volume] in Blood

9874

30900

2.06

307.65

6.3

4.7

1.91

1.99

e9/l

2.22

8845

26668

(40761511) CBC panel - Blood by Automated count

19136

81583

2.04

307.65

14.4

7.7

—

(3006504) Eosinophils/100 leukocytes in Blood

9034

27455

2.07

307.65

6.5

4.8

2.88

2.91

0.54

8514

25531

(3030467) Casts [#/volume] in Urine by Automated count

5278

15085

1.98

307.65

3.4

2.4

0.43

0.45

e6/l

0.24

4097

10457

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5772

15621

2.14

307.65

2.3

1.8

255.18

243.62

u/l

0.17

5442

14570

(3002030) Lymphocytes/100 leukocytes in Blood

9324

29197

2.01

307.65

6.6

4.8

27.80

28.90

15.48

8827

27295

(3013650) Neutrophils [#/volume] in Blood by Automated count

11015

34873

2.12

307.65

9.7

6.6

4.14

4.13

e9/l

0.09

9715

29471

(3044640) Blood type and Crossmatch panel - Blood

5861

16433

2.06

307.65

2.6

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

12604

42639

2.07

307.65

4.3

2.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3079

6884

2.44

307.65

2.7

1.7

13.13

14.32

umol/l

11.22

2875

6372

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18584

74607

2.29

307.65

15.6

7.9

24.42

25.67

mg/l

4.41

14984

53791

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16521

64845

1.98

307.65

4.4

3.5

1.98

2.31

mu/l

2.21

15190

59092

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4792

11767

2.32

307.65

2.2

1.9

2.97

2.85

mg/l

2.10

4082

9881

(3021589) Normoblasts [#/volume] in Blood

8414

27024

1.89

307.65

10.1

6.9

0.00

e9/l

0.21

6975

20892

(3013707) Erythrocyte sedimentation rate by Westergren method

13573

47555

2.05

307.65

4.1

3.0

11.68

10.44

mm/h

16.52

12614

43709

(3018010) Neutrophils/100 leukocytes in Blood

9184

28610

2.02

307.65

6.3

4.7

57.18

56.43

6.58

8684

26714

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4540

12032

2.11

307.65

2.5

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6405

19904

1.85

305.55

3.4

2.4

36.56

35.62

u/l

0.13

6088

18749

(3021960) Folate [Moles/volume] in Serum or Plasma

4203

11278

2.06

304.55

1.6

1.4

19.66

19.73

nmol/l

0.11

3648

9659

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3084

7301

2.29

302.51

2.2

1.6

29.96

29.82

0.56

2988

7094

(3018418) pH of Serum or Plasma

5406

15972

1.91

299.40

4.6

2.6

7.40

0.55

1073

3022

(40758558) Short blood count panel - Blood

4877

13928

1.96

297.60

7.3

5.2

—

(3026782) Osmolality of Urine

3899

10244

2.10

297.59

3.1

2.1

553.35

582.92

mosm/kgh2o

10.60

3348

8570

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

310

50.86

296.23

1.4

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

310

50.86

296.23

1.4

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

310

50.86

296.23

1.4

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

309

50.69

295.15

1.4

1.1

—

(36304419) Bacteria [Presence] in Urine

5163

15081

1.93

295.00

3.3

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

4068

10964

2.05

289.85

2.8

2.0

4.74

5.34

e6/l

1.92

3660

9622

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3780

9915

2.09

288.90

3.9

2.7

415.72

721.92

ng/l

4.43

2925

7553

(3017143) Hepatitis C virus Ab [Presence] in Serum

2596

5814

2.40

286.46

1.7

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

8956

31248

1.72

285.83

3.6

2.6

0.00

estimate

0.20

1865

5205

(3019309) Folate [Moles/volume] in Red Blood Cells

3421

8660

2.15

285.47

1.8

1.6

1178.17

1189.32

nmol/l

0.25

2589

6445

(3009261) Glucose [Presence] in Urine by Test strip

9017

31660

1.70

279.53

3.7

2.6

0.00

0.01

estimate

0.30

1686

4768

(3021601) Nitrite [Presence] in Urine by Test strip

8923

31279

1.70

277.73

4.9

3.5

0.00

estimate

0.55

1771

4999

(3042936) Bacteria identified in Isolate by Culture

2861

6802

2.27

276.23

2.2

1.6

—

(3044889) 12 lead EKG panel

12781

49605

1.66

267.76

3.8

2.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2236

4816

2.47

266.63

4.3

3.6

244.73

236.09

u/l

1.08

2118

4535

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19407

84784

1.94

266.31

10.9

6.7

28.76

28.21

u/l

1.63

18795

81479

(3002385) Erythrocyte distribution width [Ratio]

15955

65889

1.70

260.63

18.2

9.8

15.02

14.88

0.17

15677

63988

(3009508) Creatinine [Moles/volume] in Urine

5984

19120

1.77

252.00

3.4

2.7

8.11

8.57

mmol/l

8.93

5113

16379

(3043238) Trisomy 21 risk [Likelihood] in Fetus

250

74.60

249.13

1.5

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1785

3543

2.66

249.00

2.5

1.9

8.16

8.21

ug/l

0.02

1572

3116

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2227

4973

2.38

245.30

1.8

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17266

73424

1.72

242.27

4.4

3.6

6.00

5.84

mmol/l

41.04

15793

67435

(3007461) Platelets [#/volume] in Blood

20363

91245

2.02

238.56

22.5

11.7

246.38

249.63

e9/l

9.88

19889

87618

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2246

5102

2.34

238.07

1.9

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

20348

91193

2.02

237.12

22.7

11.7

40.65

42.07

12.02

19128

84709

(3007853) Bacteria identified in Skin by Aerobe culture

2377

5558

2.28

236.16

1.8

1.5

—

(3012544) pH of Venous blood

2032

4430

2.43

235.00

4.3

2.4

7.37

0.01

(3002032) Base excess in Venous blood by calculation

1970

4236

2.46

234.40

4.3

2.3

1.88

mmol/l

0.00

1615

3603

(3010813) Leukocytes [#/volume] in Blood

20379

91458

2.02

234.33

22.5

11.6

6.79

6.55

e9/l

29.70

19854

87421

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1979

4269

2.45

233.91

4.3

2.3

5.87

5.82

kpa

1.04

1915

4153

(3035941) MCH [Entitic mass]

20370

91418

2.01

233.79

22.4

11.6

30.33

30.28

3.45

20070

89614

(3024731) MCV [Entitic volume]

20370

91437

2.01

233.10

22.4

11.6

90.79

90.39

27.34

20073

89632

(3026361) Erythrocytes [#/volume] in Blood

20373

91460

2.01

232.92

22.5

11.6

4.55

4.66

e12/l

143.92

19851

87416

(3000963) Hemoglobin [Mass/volume] in Blood

20380

91514

2.01

232.51

22.7

11.7

137.22

140.57

g/l

164.28

20079

89761

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1404

2529

2.90

232.33

4.0

2.5

5.16

kpa

0.05

1337

2384

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16422

69192

1.66

232.09

5.7

4.3

40.15

38.76

mmol/mol

47.60

15346

64291

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1247

2093

3.10

231.57

1.5

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3777

10703

1.92

228.64

1.5

1.3

2.48

2.44

g/l

0.52

2362

7027

(40768797) Stomach Pathology biopsy report

2577

6337

2.17

227.08

1.2

—

(3009343) pH of Capillary blood

1386

2511

2.88

226.99

4.0

2.5

7.41

7.42

1.02

170

379

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3081

8184

2.03

222.86

3.1

2.4

1.91

2.15

e6/l

0.66

1729

3555

(3050129) First trimester maternal screen panel - Serum or Plasma

407

234

8.87

222.68

1.4

1.5

—

(40768804) Tissue Pathology biopsy report

7041

24255

1.66

220.66

2.1

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1798

3822

2.48

218.44

2.1

2.2

370.33

382.94

nmol/l

1.55

1653

3543

(3027801) Oxygen [Partial pressure] in Arterial blood

2311

5523

2.22

217.41

8.3

6.6

12.18

12.51

kpa

1.75

2209

5222

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2310

5525

2.22

216.89

8.3

6.6

5.11

5.10

kpa

0.12

2207

5234

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1728

3625

2.51

215.51

1.5

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1335

2445

2.85

214.32

4.0

2.5

1.55

1.80

mmol/l

1.31

1003

1759

(3033658) Prothrombin time (PT) actual/Normal

4881

15323

1.76

212.34

4.4

2.8

88.38

90.36

5.83

4760

14916

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4131

12379

1.82

208.98

1.3

1.2

1.93

1.92

u/ml

0.02

1092

3615

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1875

4163

2.37

207.60

2.3

1.9

0.21

0.22

g/l

2.44

1747

3844

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12772

51292

1.56

207.16

3.4

2.3

52.69

43.78

u/l

17.35

12018

48334

(3020682) Albumin/Creatinine [Ratio] in Urine

5617

18468

1.70

206.89

4.1

3.3

10.58

5.57

mg/mmol

9.58

3723

11679

(3003396) Base excess in Arterial blood by calculation

2301

5621

2.17

204.85

8.3

6.5

1.07

0.99

mmol/l

0.43

1811

4446

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1437

2813

2.67

204.52

1.7

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2176

5206

2.21

203.53

2.8

2.2

1.79

1.66

5.79

1933

4583

(3016502) Oxygen saturation in Arterial blood

2078

4886

2.25

202.32

8.7

7.0

95.46

95.71

0.77

2005

4669

(3015736) pH of Urine

7294

25886

1.61

198.39

3.3

2.5

5.79

5.80

0.06

544

2628

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3241

9147

1.91

195.73

2.9

2.2

0.96

1.14

e6/l

1.82

1877

4470

(3019225) pH of Specimen

1807

4062

2.34

194.30

4.6

2.7

—

(3012516) Albumin [Mass/volume] in Urine

5335

17551

1.68

194.03

3.5

2.8

351.91

292.38

mg/l

0.44

3583

11102

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2261

5621

2.13

192.20

3.1

2.1

8.50

8.61

umol/l

0.07

1974

4872

(3024354) Oxygen [Partial pressure] in Venous blood

1630

3547

2.41

187.70

3.5

2.1

4.65

4.53

kpa

1.25

1572

3437

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1398

2843

2.56

184.56

4.7

2.5

95.01

75.57

ng/l

10.41

1245

2456

(3023520) Reticulocytes [#/volume] in Blood

1601

3484

2.40

184.24

2.8

2.3

70.27

68.43

e9/l

1.00

1232

2482

(3014111) Lactate [Moles/volume] in Serum or Plasma

1835

4253

2.27

183.93

7.8

6.5

1.44

1.40

mmol/l

0.59

1783

4143

(3005719) IgG [Mass/volume] in Serum or Plasma

1563

3453

2.36

173.87

2.9

2.2

10.54

10.93

g/l

2.11

1450

3132

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1158

2198

2.73

173.79

1.7

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

1638

3723

2.30

171.13

4.5

3.3

0.94

0.91

0.11

586

1142

(3022313) Gas panel - Capillary blood

1024

1839

2.88

169.29

4.1

2.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1898

4620

2.16

168.94

9.2

7.3

123.35

126.01

g/l

5.15

1854

4473

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3270

9712

1.80

166.39

3.2

2.6

2.45

2.44

mmol/l

0.36

2857

8336

(3000991) Gas panel - Venous blood

1757

4182

2.20

164.89

9.6

6.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1801

4356

2.17

162.57

4.3

3.9

19.25

22.78

ug/l

0.21

1485

3431

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1858

4564

2.13

161.43

2.6

2.0

64.79

41.04

u/l

0.46

1613

3901

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16995

74615

1.54

159.74

4.0

3.3

1.34

1.31

mmol/l

4.15

15697

69312

(3021440) Promyelocytes/100 leukocytes in Blood

1554

3564

2.27

158.73

4.5

3.3

0.10

0.11

0.28

503

991

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17957

79920

1.58

157.35

4.8

4.0

2.73

2.89

mmol/l

95.84

16666

74557

(3020630) Protein [Mass/volume] in Serum or Plasma

1547

3558

2.27

156.95

2.7

2.0

66.63

67.09

g/l

1.26

1413

3224

(3026493) Urate [Moles/volume] in Serum or Plasma

4977

16874

1.61

155.74

2.9

2.1

4388.25

5724.69

umol/l

1.25

4383

15039

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6938

25417

1.53

155.57

3.8

2.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17682

78480

1.56

155.55

4.4

3.7

4.58

4.78

mmol/l

117.01

16514

73753

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17548

77827

1.55

153.42

4.3

3.6

1.39

1.43

mmol/l

28.74

16295

72739

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1576

3697

2.22

152.65

3.1

2.0

221.14

187.39

ng/l

1.67

1429

3316

(3002179) Metamyelocytes/100 leukocytes in Blood

1489

3412

2.27

152.20

4.2

3.3

0.70

0.60

0.78

501

937

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

914

1643

2.87

150.63

1.9

1.5

1.53

1.56

g/l

0.34

795

1390

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3790

12091

1.69

149.12

1.7

1.6

32018110.82

38963874.06

pmol/l

0.29

3167

10207

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

862

1509

2.94

148.54

2.0

1.7

1.74

2.95

ug/l

1.34

760

1361

(3037522) Nuclear Ab [Titer] in Serum

2480

6978

1.88

148.15

1.3

458.21

578.23

titre

2.04

503

1183

(3025159) Blasts/100 leukocytes in Blood

1474

3412

2.25

147.08

4.5

3.4

0.47

0.25

0.36

417

862

(3037121) Protein [Mass/volume] in Urine

738

1180

3.21

146.86

3.3

2.6

0.38

0.29

g/l

0.48

349

491

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12242

50728

1.45

145.68

3.1

2.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4176

13747

1.64

145.52

3.5

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

530

671

4.03

144.83

3.4

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1092

2223

2.54

143.12

4.6

2.3

23.94

24.33

mmol/l

3.06

1071

2178

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

144

55.93

139.28

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

882

1633

2.78

137.93

4.4

2.6

24.67

24.87

mmol/l

1.15

830

1512

(3003694) ABO and Rh group [Type] in Blood

5141

18012

1.56

137.46

1.4

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2338

6609

1.86

137.09

2.5

2.6

136.02

141.06

ug/g

0.26

1893

5422

(3028026) IgM [Mass/volume] in Serum or Plasma

1229

2734

2.33

133.78

1.9

1.7

1.31

1.29

g/l

0.09

1144

2505

(3019060) Gas panel - Arterial blood

1353

3156

2.22

132.27

5.2

3.9

—

(3000494) Fungus identified in Specimen by Culture

2262

6413

1.85

131.12

1.5

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

582

856

3.47

130.74

1.3

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

803

1453

2.84

130.65

2.1

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1243

2810

2.29

130.50

3.5

2.2

129.39

135.08

g/l

11.49

1213

2758

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

281

208

6.85

129.19

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

4826

16876

1.55

128.83

4.0

2.9

0.01

0.00

estimate

0.67

1684

4696

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1303

3060

2.21

125.21

8.6

6.0

24.77

24.71

mmol/l

0.20

1292

3029

(3004588) Protein electrophoresis panel - Serum or Plasma

1272

2963

2.22

124.57

2.4

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

497

691

3.67

120.52

6.6

1.7

995.03

916.24

iu/ml

0.06

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

736

1340

2.81

118.38

1.9

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

267

209

6.47

117.51

2.4

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2783

8665

1.70

117.12

1.2

10.69

11.55

u/ml

0.25

1101

3649

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

259

197

6.66

116.61

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4937

17695

1.51

115.93

3.4

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1993

5657

1.84

114.31

3.6

2.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2929

9355

1.65

111.71

1.2

31.48

40.76

iu/ml

1.19

937

3143

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

393

497

4.02

107.51

3.4

1.3

1643.96

5063.69

u/ml

0.82

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

702

1328

2.70

105.38

3.1

2.4

0.33

0.37

u/ml

2.55

402

709

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

487

736

3.37

105.21

1.6

1.1

19.94

16.45

u/ml

0.31

(3014007) Fractional oxyhemoglobin in Arterial blood

1274

3185

2.07

104.47

10.5

8.7

93.72

0.00

1264

3172

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1265

3165

2.06

103.50

7.6

5.8

24.47

24.46

mmol/l

0.05

1210

2987

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

299

306

4.96

103.42

1.6

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2404

7425

1.70

103.29

2.3

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

559

937

3.04

103.17

3.3

2.6

24.82

24.81

mmol/l

0.01

548

915

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1071

2513

2.19

102.73

10.9

9.4

24.29

24.39

mmol/l

0.42

1036

2418

(3019150) Specific gravity of Urine by Refractometry

4014

14075

1.52

102.66

3.9

3.0

1.02

kg/l

0.11

553

1940

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2222

6727

1.73

102.46

2.2

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1277

3220

2.05

102.35

10.3

8.5

1.40

1.37

0.36

1267

3189

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2164

6512

1.74

101.87

4.4

3.7

31.20

30.91

0.56

1538

4360

(3005322) IgE [Units/volume] in Serum or Plasma

1206

2980

2.09

101.85

1.3

1.2

265.65

309.43

u/ml

0.44

1116

2757

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

730

1437

2.60

101.72

1.4

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

816

1701

2.46

101.54

6.0

3.8

1.68

1.75

0.78

770

1569

(3022145) Colonoscopy Study observation

2046

6066

1.76

101.32

1.3

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1266

3195

2.05

101.22

10.5

8.6

0.67

0.03

1253

3171

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

485

754

3.28

100.53

1.6

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

136

16.34

100.35

6.1

3.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

136

16.34

100.35

3.0

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

805

1679

2.46

100.04

6.0

3.9

0.88

0.93

2.54

763

1549

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

523

862

3.09

99.14

1.3

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

386

517

3.79

98.29

2.5

1.4

2.64

6.50

titre

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

734

1475

2.55

98.26

2.4

2.0

506.96

635.69

ug/l

0.40

693

1393

(3023183) Ammonium ion [Moles/volume] in Plasma

492

785

3.19

98.08

3.1

2.1

36.33

36.12

umol/l

0.03

448

706

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

976

2247

2.23

97.81

3.0

2.1

1.33

0.01

967

2236

(3027273) Bicarbonate [Moles/volume] in Venous blood

951

2182

2.24

96.03

3.7

2.3

25.14

25.13

mmol/l

0.02

917

2103

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

872

1929

2.32

95.61

2.0

1.8

38.82

39.14

u/l

0.16

771

1729

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1510

4153

1.88

94.70

4.4

2.7

1.22

1.23

mmol/l

0.91

1335

3459

(40761535) Cells panel - Urine sediment

1556

4328

1.86

94.30

3.4

2.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1088

2661

2.10

94.16

11.6

8.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

494

813

3.09

93.86

1.3

1.1

274.97

233.91

u/ml

1.75

302

501

(3000570) Elastase.pancreatic [Mass/mass] in Stool

568

1021

2.84

93.31

1.4

283.93

282.17

ug/g

0.06

335

586

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

946

2199

2.21

92.63

2.9

2.1

0.64

0.65

0.40

938

2192

(3000330) Specific gravity of Urine by Test strip

912

2087

2.24

92.62

3.6

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7540

30336

1.37

89.81

4.5

4.1

3.31

2.45

ug/l

0.87

6772

27567

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

646

1275

2.59

89.51

4.2

2.0

1.55

1.28

mg/l

10.90

601

1172

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1543

4351

1.84

89.50

2.8

1.9

66.18

71.53

ml/min/173m2

4.13

579

1528

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

440

696

3.21

88.87

1.6

1.1

123.35

104.02

u/ml

1.23

157

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

628

1226

2.61

88.84

2.9

2.0

3.52

3.76

g/l

2.64

595

1167

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

882

2030

2.23

88.34

4.2

2.7

50.06

48.91

0.58

870

2006

(3045414) Leukocytes [Presence] in Urine

803

1782

2.31

87.36

1.9

1.5

—

(3024932) HLA-DR beta [Type]

100

28.00

86.25

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

242

241

5.08

86.06

1.5

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1018

2513

2.08

85.93

2.9

2.2

0.23

0.31

e6/l

1.30

988

2442

(3024471) HLA-A [Type]

101

25.45

85.19

1.0

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

551

1027

2.73

84.91

3.8

2.5

8.28

8.43

kpa

1.02

538

998

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

511

915

2.84

84.50

1.8

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2288

7349

1.62

83.71

7.5

5.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

716

1555

2.35

81.62

2.3

1.9

7.35

7.40

g/l

0.23

652

1398

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

715

1552

2.35

81.60

2.3

1.9

3.70

3.88

g/l

2.05

651

1396

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

716

1556

2.35

81.51

2.3

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

659

1377

2.44

81.49

2.8

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2834

9644

1.54

81.16

1.9

1.6

1.51

1.34

19.56

2512

8748

(3034274) Bile acid [Moles/volume] in Serum --fasting

191

159

6.07

80.02

2.5

1.8

7.21

14.62

umol/l

1.09

142

114

(3009445) Proteinase 3 Ab [Units/volume] in Serum

854

2030

2.15

79.14

1.6

1.5

18.31

10.56

u/ml

0.58

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

692

1502

2.35

78.97

3.7

3.0

6031.69

5834.67

u/ml

0.01

589

1280

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

706

1550

2.33

78.59

1.6

1.5

245.19

380.00

titre

0.53

(3024928) Oxygen saturation in Venous blood

487

886

2.80

78.34

3.1

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

296

385

3.90

78.28

6.3

4.9

11.43

11.14

mg/l

0.38

272

345

(3011288) Drugs identified in Urine by Screen method

756

1720

2.25

77.69

3.7

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

490

903

2.76

77.06

1.9

1.3

—

(4035726) Immunohistochemistry procedure

1512

4437

1.76

76.68

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

1491

4360

1.77

76.51

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

110

79.24

75.69

5.2

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

779

1818

2.19

75.42

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

325

474

3.48

73.90

2.1

1.4

1260.00

6128.00

titre

—

(3010375) cycloSPORINE [Mass/volume] in Blood

124

10.09

73.71

26.3

10.2

118.76

142.97

ug/l

0.44

100

(3014051) Protein [Presence] in Urine by Test strip

474

884

2.73

72.97

2.5

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

463

855

2.75

72.55

1.7

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

739

1719

2.20

72.09

4.1

3.7

1.38

1.40

mmol/l

0.12

725

1695

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

353

555

3.23

72.00

1.9

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

353

555

3.23

72.00

1.9

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

667

1494

2.28

70.99

2.4

1.9

2.95

3.01

g/l

0.64

602

1338

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

669

1510

2.26

69.98

2.4

1.9

10.33

10.46

g/l

0.26

602

1347

(4146454) Self-monitoring of blood glucose

222

249

4.51

69.86

2.7

1.8

—

(3036489) Thrombin time

770

1848

2.13

69.63

2.3

1.6

21.54

21.29

0.37

683

1569

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

943

2457

1.97

68.72

2.4

2.3

—

(3021901) Oxygen saturation in Capillary blood

410

736

2.83

67.54

2.8

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

665

1521

2.23

67.47

2.6

1.7

91.80

92.79

0.48

647

1444

(3009214) Lutropin [Units/volume] in Serum or Plasma

694

1632

2.17

65.94

1.5

1.4

7.48

7.70

u/l

0.18

555

1347

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

536

1126

2.42

65.54

1.4

1.2

546.14

565.98

mg/l

0.14

503

1071

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

595

1313

2.31

65.47

2.7

2.0

187.36

185.80

0.14

565

1239

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3410

12600

1.42

63.48

1.6

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2096

7022

1.55

63.33

2.4

2.0

13.39

13.83

nmol/l

1.54

1887

6488

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

563

1232

2.33

63.10

3.4

2.6

2.54

1.45

ratio

0.56

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

575

1271

2.30

63.03

3.4

2.6

73.69

38.14

mg/l

0.86

469

952

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

476

967

2.50

62.32

1.3

1.1

—

(3002256) Pathology report gross observation

2271

7776

1.52

62.10

1.3

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

574

1277

2.29

62.03

3.4

2.6

64.68

70.41

mg/l

0.08

467

960

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

396

735

2.73

61.53

3.7

3.4

1034.35

1083.62

u/ml

0.02

373

673

(3009466) Valproate [Moles/volume] in Serum or Plasma

369

658

2.84

61.51

5.7

4.1

373.70

359.36

umol/l

1.00

328

558

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

602

1377

2.23

61.06

1.8

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

368

660

2.83

60.75

2.0

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

396

742

2.71

60.49

1.6

—

(3010421) pH of Blood

599

1376

2.22

60.16

4.7

2.7

7.42

1.68

528

1295

(3017732) Neutrophils [#/volume] in Blood

1271

3803

1.72

59.90

3.1

2.5

6.04

5.06

e9/l

0.74

1051

3187

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

602

1390

2.20

59.74

2.5

2.0

1.24

0.83

g/l

1.09

529

1196

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

556

1246

2.27

59.11

2.1

1.8

11.98

10.37

mg/l

1.11

507

1190

(3013139) Helicobacter pylori Ag [Presence] in Stool

1176

3456

1.75

58.98

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

472

988

2.43

58.16

1.3

1.2

3.83

3.71

mmol/l

1.33

441

920

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

410

800

2.60

58.09

1.4

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

677

1660

2.08

57.97

1.6

8.73

0.25

iu/ml

0.50

142

349

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1172

3460

1.74

57.85

2.3

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

564

1289

2.23

57.32

2.5

2.1

3942.75

2802.22

u/l

0.43

216

293

(1616796) Gas panel - Central venous blood

487

1043

2.37

57.20

4.1

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

332

583

2.89

56.84

4.0

2.6

1.43

1.58

0.25

307

516

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1239

3747

1.70

56.13

2.4

2.3

21.82

23.72

au/ml

0.27

367

(44816559) Phosphatidylethanol [Mass/volume] in Blood

455

952

2.43

56.13

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

307

520

2.99

55.81

1.1

—

(3049717) Cytology report of Urine Cyto stain

764

1988

1.96

55.80

2.7

2.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1003

2857

1.80

55.78

3.4

3.5

4.54

4.63

pmol/l

1.63

887

2564

(3047181) Lactate [Moles/volume] in Blood

635

1545

2.09

55.45

6.9

4.1

1.36

1.29

mmol/l

0.80

562

1332

(1001926) Buprenorphine [Presence] in Urine by Screen method

875

2392

1.87

55.35

2.7

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

372

709

2.66

55.10

3.1

2.9

0.85

0.77

nmol/l

1.54

285

569

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

248

370

3.39

54.72

1.5

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

233

334

3.53

54.38

1.9

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4646

18468

1.33

54.03

1.7

1.6

1.44

1.37

mmol/l

4.58

3976

15299

(3008037) Lactate [Moles/volume] in Venous blood

420

863

2.47

53.78

3.3

2.1

1.63

1.70

mmol/l

0.45

410

847

(3020891) Body temperature

814

2193

1.89

53.78

4.9

4.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1139

3409

1.71

53.51

1.3

1.2

59.79

53.45

au/ml

0.33

217

(3017354) Segmented neutrophils/100 leukocytes in Blood

205

270

3.84

53.50

3.9

2.5

55.80

57.61

0.44

183

227

(3024522) Salmonella sp identified in Specimen by Organism specific culture

248

376

3.34

53.48

1.5

1.2

—

(3025941) Bacteria identified in Stool by Culture

1083

3196

1.74

53.46

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

690

1759

2.00

53.32

1.6

1.7

294.17

292.19

mu/l

0.05

634

1601

(3036180) Methadone [Presence] in Urine

152

154

4.98

53.30

3.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

246

372

3.34

53.25

1.5

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

434

912

2.41

53.08

3.6

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

245

371

3.34

52.93

1.5

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

251

387

3.28

52.82

1.5

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

168

189

4.49

52.80

1.3

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

245

372

3.33

52.73

1.5

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

557

1312

2.16

52.71

2.3

1.9

37.70

37.80

g/l

0.12

493

1154

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

540

1258

2.18

52.48

1.3

1.5

5.08

12.89

iu/ml

1.76

(3014148) Varicella zoster virus Ab [Titer] in Serum

287

486

2.99

52.23

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

466

1021

2.32

52.12

1.5

1.3

30.07

28.41

e6/l

0.03

364

748

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

466

1021

2.32

52.12

1.5

1.3

757.28

1148.86

e6/l

0.25

377

787

(3003181) Sodium [Moles/volume] in Urine

338

632

2.71

51.88

1.4

1.3

64.35

63.93

mmol/l

0.05

276

494

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

549

1301

2.15

51.20

1.7

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

593

1450

2.08

51.14

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1863

6368

1.51

50.86

1.6

1.4

—

(3022621) pH of Urine by Test strip

1136

3452

1.69

50.48

3.0

2.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.74

50.44

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

398

823

2.45

50.33

1.2

346.00

88.89

titre

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

535

1266

2.15

50.08

2.3

1.9

0.02

g/l

0.16

492

1151

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

310

564

2.78

49.98

3.3

2.7

93.85

174.00

u/ml

0.29

303

555

(3014765) Yersinia sp identified in Stool by Organism specific culture

588

1449

2.06

49.71

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.93

49.43

1.1

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

460

1027

2.27

49.35

2.6

1.9

16.46

17.57

4.92

241

459

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

364

735

2.51

48.31

1.6

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

581

1445

2.04

47.96

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

619

1577

2.00

47.92

4.3

3.8

3.93

3.88

mmol/l

1.27

611

1562

(3034770) Mitochondria Ab [Titer] in Serum

553

1355

2.07

47.45

1.3

1.2

898.18

1621.82

titre

1.05

(4200892) Spirometry reversibility

1261

4009

1.61

47.06

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

748

2049

1.86

46.99

1.1

0.81

5.91

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

552

1359

2.06

46.79

1.5

1.19

g/l

0.11

521

1300

(3011412) CD3 cells [#/volume] in Blood

210

312

3.40

46.69

2.6

2.1

1.28

1.11

e9/l

1.42

189

284

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

209

310

3.41

46.58

2.0

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

206

303

3.43

46.46

2.7

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

554

1375

2.05

45.99

1.3

1.2

81.58

156.57

titre

1.62

134

(3038515) Glucose [Moles/volume] in Venous blood

393

844

2.36

45.95

3.4

2.1

7.65

7.87

mmol/l

0.67

384

829

(3037756) Immunofixation for Serum or Plasma

386

823

2.38

45.83

1.7

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

250

424

2.98

45.44

1.7

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

250

424

2.98

45.44

1.7

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

974

2925

1.70

45.12

2.2

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

502

1209

2.11

45.01

2.3

1.9

0.00

g/l

0.50

460

1098

(3023419) Bacteria identified in Sputum by Culture

296

558

2.68

44.82

3.2

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

156

191

4.12

44.60

3.2

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

502

1215

2.10

44.46

4.8

2.8

5.04

4.96

kpa

1.17

492

1187

(3027315) Oxygen [Partial pressure] in Blood

503

1219

2.09

44.40

4.8

2.8

8.58

8.67

kpa

0.45

492

1191

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

153

185

4.17

44.39

2.9

2.1

0.23

0.26

e9/l

0.77

134

160

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

497

1199

2.10

44.38

2.4

1.9

0.00

g/l

-0.00

459

1095

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

299

571

2.65

44.21

1.8

1.3

—

(3012501) Base excess in Blood by calculation

501

1215

2.09

44.15

4.8

2.8

2.52

2.28

mmol/l

0.96

328

780

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

530

1315

2.05

44.04

1.5

0.24

g/l

0.36

501

1254

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

156

194

4.06

43.79

2.9

2.1

599.85

500.75

e6/l

0.73

134

163

(21494815) CD4 cells/100 lymphocytes in Specimen

195

289

3.41

43.54

2.4

2.1

38.56

38.89

0.09

195

282

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

241

413

2.95

43.09

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

294

567

2.62

42.70

1.6

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

365

784

2.36

42.69

1.1

1.0

—

(3003338) MCHC [Mass/volume]

15668

73113

1.24

42.37

19.6

10.2

333.50

334.13

g/l

12.49

15520

72312

(3015171) Extractable nuclear Ab [Units/volume] in Serum

664

1811

1.86

42.27

1.2

0.62

0.76

u/ml

0.14

202

(3016879) Cocaine [Presence] in Urine

1019

3161

1.65

41.82

2.7

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

229

389

2.97

41.56

4.9

3.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

446

1060

2.13

41.36

1.4

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

315

641

2.49

41.23

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

446

1062

2.13

41.17

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

146

182

4.05

40.90

2.8

2.5

41.33

37.30

1.00

(3044927) Protein electrophoresis panel - Urine

206

331

3.14

40.85

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

15.65

40.79

6.1

6.4

71.83

76.54

0.37

(3000764) Benzodiazepines [Presence] in Urine

1078

3414

1.61

40.77

2.6

1.4

—

(3018572) Chloride [Moles/volume] in Blood

449

1079

2.11

40.51

8.2

4.8

105.36

104.96

mmol/l

0.82

410

958

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5896

24926

1.25

40.43

3.9

3.8

21.54

21.86

0.73

2587

11159

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

666

1847

1.83

40.28

1.7

—

(3039000) Anion gap in Blood

448

1079

2.11

40.20

8.2

4.8

11.47

11.37

mmol/l

0.22

409

958

(3028300) Cannabinoids [Presence] in Urine

1087

3471

1.60

39.75

2.6

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

220

375

2.96

39.73

2.4

2.1

1.60

1.33

g/24h

0.42

115

179

(3024980) IgG subclass 4 [Mass/volume] in Serum

338

726

2.36

39.57

1.6

1.7

0.79

0.99

g/l

1.78

266

524

(3027008) Opiates [Presence] in Urine

1085

3469

1.60

39.47

2.4

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

644

1784

1.83

39.09

1.8

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

277

546

2.56

38.64

1.5

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

166

242

3.46

38.00

1.8

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

244

454

2.72

37.92

2.7

1.7

—

(3008295) Osmolality of Serum or Plasma

231

422

2.76

37.11

1.3

1.5

283.11

280.44

mosm/kgh2o

0.66

171

340

(3028271) Lactate [Moles/volume] in Capillary blood

344

769

2.26

36.91

2.0

1.5

1.71

1.86

mmol/l

1.48

337

752

(3044290) Cell count panel - Cerebral spinal fluid

418

1015

2.09

36.78

1.5

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

210

366

2.90

36.59

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

246

470

2.64

36.44

1.9

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

563

1528

1.87

36.41

3.3

2.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

8.35

36.31

1.5

1.6

—

(3027944) Amphetamines [Presence] in Urine

1061

3443

1.57

36.25

2.5

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

470

1206

1.98

35.75

4.5

2.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

174

274

3.20

35.65

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

174

274

3.20

35.65

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

174

274

3.20

35.65

1.9

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

431

1073

2.04

35.57

1.2

9.38

10.48

u/ml

0.10

140

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

122

148

4.15

35.36

1.4

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

454

1155

1.99

35.35

1.2

30.88

39.09

u/ml

0.21

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

414

1022

2.05

34.94

1.6

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

425

1061

2.03

34.82

1.2

3.18

11.79

u/ml

0.93

(3017569) Oxygen content in Arterial blood

105

113

4.68

34.77

2.6

2.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

122

151

4.07

34.54

1.4

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

597

1685

1.80

34.18

1.3

1.2

228.23

224.49

miu/ml

0.08

255

808

(3020961) Endomysium IgA Ab [Titer] in Serum

897

2835

1.61

34.17

1.1

190.05

218.72

titre

0.17

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

107

4.75

34.00

2.6

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

302

661

2.31

34.00

1.1

1.0

1.49

g/l

0.00

273

597

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

101

4.79

32.57

2.6

1.7

—

(1175426) CD3 cells/100 lymphocytes in Blood

161

257

3.16

32.36

2.2

1.9

74.03

72.73

0.42

154

246

(21494755) Public health laboratory ask at order entry panel

1811

12093

0.73

32.33

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

666

1974

1.71

32.33

2.0

1.8

208.49

213.17

pmol/l

0.49

631

1901

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

6.62

32.22

1.9

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

341

807

2.14

32.05

1.2

1.3

45.67

22.57

u/l

1.61

300

696

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

159

254

3.16

31.93

2.2

1.9

14.55

16.01

0.84

154

246

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

199

366

2.74

31.66

2.1

2.3

21.47

18.85

nmol/l

2.03

188

348

(3016650) Hepatitis A virus Ab [Presence] in Serum

354

855

2.09

31.64

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

198

364

2.74

31.53

3.1

2.7

71.75

31.80

mg/l

0.72

146

248

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

345

827

2.11

31.43

1.2

5.27

8.85

u/ml

0.30

(40768446) Kidney Pathology biopsy report

104

122

4.29

31.39

1.8

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

145

221

3.31

31.24

11.5

10.5

0.60

0.62

mmol/l

0.29

132

199

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

313

726

2.18

30.90

1.2

5.11

3.76

u/ml

0.67

141

328

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

173

298

2.93

30.83

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

176

311

2.85

30.06

1.1

287.05

266.75

mg/l

0.49

154

267

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1099

3748

1.50

29.96

1.2

129.81

145.08

iu/ml

0.59

402

1517

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

322

768

2.12

29.73

1.3

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

311

732

2.15

29.66

1.7

1.4

—

(3042631) Mycobacterium sp identified in Specimen

271

604

2.27

29.38

3.0

2.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

132

197

3.38

29.35

1.1

3.86

9.09

nmol/l

0.86

(3006184) Hemoglobin [Mass/volume] in Capillary blood

447

1209

1.87

29.28

2.2

1.8

131.39

137.00

g/l

4.17

338

890

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

211

420

2.54

29.01

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

180

329

2.76

29.01

1.2

1.1

44.07

46.29

mg/l

0.19

152

272

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

364

920

2.00

28.94

1.8

1.6

—

(3045424) Erythrocytes [Presence] in Urine

306

723

2.14

28.93

1.5

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

104

131

4.00

28.91

2.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

104

131

4.00

28.91

2.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

112

4.27

28.55

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

112

4.27

28.55

1.4

1.2

—

(3000492) Spirometry study

1966

7501

1.34

28.53

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

146

238

3.09

28.47

2.2

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

320

775

2.09

28.45

1.2

4.01

5.01

u/ml

0.27

109

274

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

337

836

2.04

28.17

4.1

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

228

479

2.40

28.13

1.6

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

251

552

2.30

28.06

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

256

570

2.27

27.84

1.5

1.4

31.99

33.89

g/l

1.30

222

510

(3004716) Salmonella sp identified in Stool by Organism specific culture

992

3366

1.50

27.70

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.90

27.70

2.1

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

203

408

2.51

27.42

4.3

3.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

265

606

2.21

27.12

1.3

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

143

3.73

27.07

2.5

1.4

143.92

78.14

umol/l

1.44

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

104

4.31

27.04

2.5

3.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

934

3145

1.51

27.04

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

166

304

2.75

26.70

1.3

1.1

2.05

2.00

mmol/l

0.26

158

282

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

5.18

26.49

2.4

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

889

2978

1.52

26.36

1.9

1.6

38.07

38.99

nmol/l

0.56

857

2936

(3004616) Nuclear Ab [Presence] in Serum

210

439

2.41

26.21

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4269

18130

1.22

26.09

2.9

2.7

0.75

0.76

ug/l

0.20

2689

10663

(40761536) Microorganisms panel - Urine sediment

1549

5780

1.37

25.83

4.2

2.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

449

1268

1.79

25.75

1.7

1.6

16318.07

13845.30

e6/l

0.34

319

926

(4062490) Immunoglobulin typing, IgG

202

420

2.43

25.51

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

202

423

2.41

25.15

1.3

2.96

3.14

g/l

0.61

144

268

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.83

25.13

1.1

—

(40768441) Liver Pathology biopsy report

145

256

2.85

24.89

1.5

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

114

173

3.32

24.83

2.3

1.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

201

423

2.40

24.77

1.3

0.38

0.44

g/l

1.01

142

267

(3027135) IgG subclass 1 [Mass/volume] in Serum

201

423

2.40

24.77

1.3

6.64

7.24

g/l

1.13

144

268

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

508

1508

1.71

24.61

1.4

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

144

256

2.83

24.44

1.6

1.7

—

(3017704) Immunofixation for Urine

120

191

3.16

24.35

1.5

1.3

—

(3014271) Vancomycin [Susceptibility]

111

168

3.33

24.28

2.9

2.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

313

800

1.98

24.22

1.9

2.0

5.10

5.58

mmol/24h

1.42

274

729

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

178

357

2.51

24.21

1.1

286.87

283.73

mg/l

0.16

160

324

(3013005) Retinol [Moles/volume] in Serum or Plasma

132

3.66

23.97

1.9

1.4

1.94

1.95

umol/l

0.05

121

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

321

832

1.95

23.90

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

303

770

1.99

23.83

1.1

114.12

117.02

0.87

282

687

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

120

194

3.12

23.79

2.0

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.44

23.63

3.3

2.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

102

149

3.45

23.48

1.9

1.4

27.51

28.40

umol/l

0.31

138

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

495

1479

1.69

23.44

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.35

23.38

2.4

1.1

32116.07

1808.08

u/ml

0.50

(3027923) C peptide [Moles/volume] in Serum or Plasma

127

216

2.96

23.24

1.4

1.6

1.27

1.16

nmol/l

0.47

179

(3020191) Ethanol [Moles/volume] in Serum or Plasma

198

427

2.34

23.20

1.5

1.2

1.39

1.32

promille

0.20

155

327

(3016038) Potassium [Moles/volume] in Urine

136

242

2.83

23.08

1.3

1.2

36.27

38.81

mmol/l

0.50

123

219

(3038026) Centromere Ab [Units/volume] in Serum

144

265

2.74

23.04

1.1

1.2

64.03

60.37

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

229

529

2.18

22.97

1.3

—

(3008898) HLA-B27 [Presence]

644

2070

1.58

22.95

1.1

1.0

—

(21494434) Karyotype in Bone marrow

167

335

2.51

22.74

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

627

2007

1.58

22.74

1.5

1.3

23.26

30.08

iu/l

5.38

516

1716

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

195

422

2.33

22.69

1.6

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

102

4.00

22.62

2.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

102

4.00

22.62

2.5

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

182

382

2.40

22.61

1.6

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

473

1410

1.70

22.60

2.3

2.1

142.43

76.41

ug/min

1.49

286

862

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

519

1589

1.65

22.47

1.3

—

(3045142) Bone marrow Pathology biopsy report

203

450

2.28

22.41

1.4

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

244

585

2.10

22.37

1.3

1.2

0.35

0.19

nmol/l

0.50

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

411

1181

1.76

22.32

1.8

5.55

4.33

iu/l

0.91

136

448

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

216

493

2.21

22.31

1.2

1.1

—

(40768443) Skin Pathology biopsy report

764

2571

1.51

22.21

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

106

3.89

22.19

2.5

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

264

656

2.03

22.09

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

420

1221

1.74

21.94

2.0

1.4

0.86

0.81

nmol/l

0.54

350

1084

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

140

261

2.70

21.91

1.1

1.2

61.86

51.91

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

166

339

2.47

21.83

1.6

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

117

3.70

21.82

2.6

1.8

9.72

11.88

0.52

108

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

139

259

2.70

21.78

1.1

1.2

82.80

69.43

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

115

3.72

21.72

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

213

490

2.19

21.61

2.5

1.7

22.05

26.07

mg/l

0.52

128

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.42

21.22

2.1

1.6

15.56

15.39

umol/l

0.03

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

+∞

21.05

1.2

0.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

111

3.72

20.96

2.4

1.6

29.09

29.30

0.04

102

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

244

601

2.05

20.92

1.3

0.61

2.86

nmol/l

0.61

235

580

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

128

234

2.75

20.77

1.1

1.07

1.05

u/l

0.19

111

(3023199) Leukocytes [#/volume] in Pleural fluid

225

539

2.11

20.72

1.5

1.4

1724.66

3692.23

e6/l

2.14

165

379

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

170

361

2.37

20.65

15.9

11.1

787.54

858.25

nmol/l

1.02

164

346

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

233

568

2.07

20.53

1.1

97.74

99.54

0.43

221

533

(3000012) Reticulocyte production index

256

648

1.99

20.43

1.9

2.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

174

3.04

20.10

1.7

1.3

1509625.00

2273843.60

iu/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

194

443

2.21

20.07

2.1

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

569

1838

1.57

19.90

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

103

170

3.05

19.85

1.4

1.6

9.03

8.03

ug/l

0.20

156

(3000093) Morphology [Interpretation] in Blood Narrative

190

433

2.21

19.76

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

209

496

2.12

19.72

1.4

21.24

28.41

u/l

2.41

166

417

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

211

504

2.11

19.60

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

427

1292

1.67

19.39

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

4.15

19.34

2.4

1.7

192.00

3894.29

e6/l

0.65

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

111

195

2.87

19.34

1.8

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

111

195

2.87

19.34

1.8

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

127

241

2.65

19.31

3.4

3.2

25.60

28.18

mu/l

0.32

122

226

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

198

2.85

19.30

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

146

298

2.47

19.29

1.4

1.2

1.06

2.48

u/ml

1.22

127

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

102

171

3.00

19.19

4.9

3.5

—

(3012441) Differential panel - Pleural fluid

201

475

2.13

19.18

1.4

1.5

—

(3042517) Benzodiazepines panel - Urine

10.05

19.14

2.6

2.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

325

919

1.79

18.70

1.2

54.10

46.01

u/ml

0.23

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

139

3.22

18.70

1.8

1.6

143.73

142.04

0.05

130

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.43

18.63

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

126

243

2.61

18.61

1.4

8.51

6.43

u/l

0.65

107

205

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

129

252

2.58

18.59

1.1

1.2

5.60

6.32

u/ml

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

173

390

2.24

18.48

1.3

357.80

549.59

u/l

1.28

164

369

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

165

366

2.27

18.29

1.8

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

103

3.61

18.29

1.8

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

136

276

2.48

18.20

1.1

—

(3021788) Differential panel - Synovial fluid

343

997

1.74

18.02

1.6

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

122

3.34

17.96

2.6

1.5

878.79

1761.44

e6/l

0.66

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1860

7488

1.27

17.92

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.24

17.91

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

297

2.41

17.88

1.6

1.3

—

(40768806) Pleura Pathology biopsy report

200

486

2.07

17.84

1.4

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

145

309

2.36

17.57

1.9

1.5

4.93

3.35

mg/l

2.75

140

290

(3023410) Appearance of Cerebral spinal fluid

210

524

2.02

17.50

1.8

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

210

524

2.02

17.50

1.3

1.2

—

nmol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

188

450

2.11

17.43

1.3

1.36

1.46

nmol/l

0.51

172

404

(3022689) Creatine [Moles/volume] in Urine

4.00

17.43

1.4

—

(3028433) Virus identified in Specimen by Culture

100

3.57

17.30

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

105

3.50

17.29

1.2

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

140

296

2.38

17.26

1.7

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

125

250

2.52

17.25

7.8

3.5

205.72

3534.29

u/ml

0.49

(3016018) Differential panel - Cerebral spinal fluid

216

548

1.99

17.22

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

140

297

2.37

17.14

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

139

294

2.38

17.12

1.2

—

(3051651) Icteric interference index of Serum or Plasma

125

254

2.48

16.73

3.7

3.1

—

(3048879) Bone marrow aspiration report

4.25

16.65

2.1

1.2

—

(3016750) Collection duration of Urine

129

267

2.43

16.64

2.2

1.7

494.91

505.46

min

0.53

183

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

504

1655

1.54

16.49

1.1

6.71

5.57

u/ml

0.20

298

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

128

267

2.41

16.26

1.4

1.6

19.67

23.26

u/ml

0.46

(3006576) Bicarbonate [Moles/volume] in Blood

153

2.93

16.16

6.5

5.0

24.90

24.67

mmol/l

0.19

142

(3028308) Erythrocytes [#/volume] in Pleural fluid

196

493

2.00

16.03

1.4

66623.89

52289.28

e6/l

0.23

124

288

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

4.56

16.03

2.2

2.3

1.19

1.13

mmol/l

0.06

(3004775) Volume in Urine collected for unspecified duration

163

382

2.15

15.97

2.3

1.8

651.51

639.61

0.13

105

234

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.71

15.93

7.2

5.7

—

(3006653) Thiamine [Moles/volume] in Blood

107

206

2.61

15.93

1.2

143.20

131.98

nmol/l

1.34

107

206

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

104

3.39

15.88

1.4

1.2

137.38

135.76

nmol/l

0.02

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

110

216

2.56

15.78

2.2

2.4

153.70

138.60

nmol/l

0.80

189

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

212

557

1.92

15.38

4.0

2.8

30.12

35.73

u/ml

0.25

207

531

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

103

199

2.60

15.25

1.2

70.00

77.00

0.31

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

142

2.94

15.21

1.4

1.3

62.94

59.27

0.33

119

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

176

434

2.04

15.20

1.3

1.2

160.32

197.66

titre

0.24

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

176

434

2.04

15.20

1.3

1.2

213.33

302.00

titre

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

330

1002

1.66

14.91

1.1

117.45

992.96

iu/ml

0.49

205

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.80

14.88

7.3

5.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

221

597

1.87

14.80

1.4

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

132

293

2.27

14.72

1.4

1.3

13.93

12.03

u/l

1.68

123

287

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.47

14.48

2.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

203

537

1.91

14.48

1.3

1.2

58.68

53.53

u/ml

0.07

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

177

446

2.00

14.46

1.2

1.1

62.74

72.52

u/l

0.45

162

387

(3022493) Free Hemoglobin [Mass/volume] in Plasma

167

2.71

14.38

5.1

1.2

67.47

9122.88

mg/l

1.83

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

159

387

2.07

14.24

1.6

1.3

12.98

11.43

umol/l

1.98

150

369

(3004451) EKG impression Narrative

104

210

2.49

14.18

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

3.03

14.11

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

111

232

2.41

14.11

3.9

2.8

—

(3045788) Cell count panel - Pleural fluid

173

437

1.99

14.06

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

234

656

1.80

13.99

1.7

1.5

59.55

55.60

0.70

153

415

(3036782) Glucose [Moles/volume] in Pleural fluid

176

450

1.97

13.85

1.4

1.3

6.54

5.97

mmol/l

1.73

164

409

(3029396) Erythrocyte agglutination [Presence] in Blood

5.50

13.77

2.8

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

117

255

2.31

13.62

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

277

824

1.70

13.55

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.95

13.50

1.3

854.89

184.78

u/l

0.37

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

170

434

1.97

13.45

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

248

2.31

13.34

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

110

236

2.35

13.27

2.4

1.7

27.06

52.60

umol/l

0.87

(40765096) Chromosome analysis panel by Banding

115

3.02

13.25

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

305

939

1.64

13.14

1.1

8.96

10.61

au/ml

0.23

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

116

2.99

13.08

2.3

1.5

25480.80

3024.29

e6/l

0.48

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.23

13.01

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

124

284

2.20

12.93

1.0

277.69

367.96

ng/l

1.73

223

(3044941) Cell count panel - Synovial fluid

298

916

1.64

12.93

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

148

2.72

12.90

2.0

2.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

149

368

2.04

12.90

1.1

—

(40757373) Influenza virus identified in Isolate

3.58

12.83

1.8

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

271

815

1.68

12.77

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

111

244

2.29

12.72

1.1

99.46

76.33

u/l

1.21

209

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

325

1028

1.60

12.60

1.1

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

9.21

12.55

1.2

1.0

27.33

11.17

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

238

694

1.73

12.53

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

123

286

2.16

12.40

1.0

755.52

687.48

ng/l

0.62

211

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

123

286

2.16

12.40

1.0

42.66

45.67

ng/l

0.22

223

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

109

241

2.28

12.35

1.4

1.2

829.00

323.70

titre

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

119

274

2.19

12.29

1.7

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

115

261

2.22

12.28

2.1

2.97

3.19

ug/l

0.15

104

233

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

140

345

2.04

12.22

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

118

272

2.18

12.16

1.7

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

7.53

12.09

1.3

1.4

40.67

36.31

umol/l

0.30

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

155

399

1.96

12.04

2.0

1.9

1.82

1.73

u/field

0.05

177

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.83

12.03

2.3

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

183

499

1.85

12.01

3.4

2.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

595

2155

1.40

11.97

3.1

2.4

66.07

41.20

u/ml

1.29

572

2092

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

105

232

2.28

11.93

1.4

1.2

73.08

129.29

titre

0.26

(3028679) Herpes simplex virus Ab [Presence] in Serum

105

232

2.28

11.93

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.26

11.92

1.7

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

108

242

2.25

11.89

1.2

1.1

3.80

4.89

iu/ml

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

132

322

2.06

11.84

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

132

324

2.05

11.67

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

106

238

2.24

11.63

1.1

20.03

22.42

u/l

0.24

199

(40758292) HTLV I+II Ab panel - Serum

3.91

11.62

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

188

2.41

11.55

1.1

1571.31

1530.61

miu/ml

0.11

188

(3006922) Hepatitis E virus Ab [Presence] in Serum

141

357

1.99

11.49

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.03

11.45

1.3

1.1

91.13

88.86

0.14

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.22

11.39

1.0

0.06

0.26

u/ml

0.44

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

2.95

11.36

1.0

1.1

90.15

94.82

0.50

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.73

11.22

7.4

5.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

252

2.18

11.19

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.50

11.07

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

3.66

10.98

2.1

1.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

138

2.62

10.96

1.4

1.3

2.60

3.94

0.49

117

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

394

1344

1.48

10.96

4.1

3.2

57.21

57.06

0.08

394

1344

(3025577) Chromium [Mass/volume] in Blood

111

261

2.14

10.96

2.1

2.2

2.02

2.06

ug/l

0.05

220

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

104

238

2.20

10.95

2.2

2.5

47.50

53.16

umol/l

1.00

200

(3033799) Differential panel - Peritoneal fluid

115

2.80

10.93

2.3

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

118

2.77

10.91

1.2

110.09

112.87

0.28

102

(3040151) Glucose [Moles/volume] in Capillary blood

231

696

1.67

10.89

5.9

5.1

7.11

7.34

mmol/l

0.48

194

566

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.35

10.87

1.4

1.2

26.97

26.88

g/l

0.01

(4094501) Cardiovascular stress test using bicycle ergometer

501

1794

1.41

10.80

1.1

—

(3044007) Cell count panel - Peritoneal fluid

108

2.84

10.69

2.3

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.48

10.69

2.5

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

380

1294

1.48

10.67

3.8

3.0

4.11

4.05

e9/l

0.19

380

1294

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.84

10.59

1.1

1.2

39.85

52.74

mg/l

0.57

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

106

249

2.14

10.51

2.1

2.2

149.05

81.15

ug/min

0.41

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.26

10.46

1.6

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

139

2.57

10.41

1.4

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

145

2.53

10.41

1.6

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

3.77

10.35

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.47

10.34

2.2

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.89

10.33

1.5

1.1

13.12

11.94

g/l

0.37

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

232

715

1.63

10.08

1.6

1.3

0.25

0.26

nmol/l

0.12

185

555

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.93

10.07

1.5

1.3

272421.12

871803.97

nmol/l

0.48

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

227

696

1.64

10.07

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

118

2.68

10.04

1.1

1.0

—

(3035880) pH of Pleural fluid

103

244

2.12

10.03

1.4

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.26

10.02

1.4

1.3

24.76

19.88

0.48

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

127

2.61

10.01

1.2

0.29

0.30

g/l

0.66

(3000919) Neutrophils/100 leukocytes in Pleural fluid

119

2.66

9.89

1.4

1.3

26.06

26.89

0.07

106

(21491868) Cryoglobulin [Mass/volume] in Serum

149

2.46

9.89

1.3

1.1

0.08

0.15

g/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

18.08

9.88

3.1

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

135

357

1.90

9.81

1.8

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.40

9.76

1.1

1.2

0.76

0.65

umol/24h

0.65

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

2.64

9.75

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

107

261

2.06

9.70

1.4

1.2

—

(3011985) Renin [Units/volume] in Plasma

228

710

1.62

9.54

1.4

1.6

47.07

71.71

mu/l

0.89

203

648

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.50

9.42

1.3

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.21

9.41

1.2

57.69

58.11

0.01

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

111

2.67

9.35

1.1

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.54

9.32

1.2

1.3

90.15

135.24

ng/l

0.30

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

3.23

9.27

1.1

1.2

12.27

8.91

u/ml

0.11

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

109

2.67

9.22

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.68

9.18

1.2

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

124

327

1.91

9.12

1.3

1.2

12.58

15.50

u/l

0.78

113

311

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

2.60

9.06

1.3

1.7

9.06

8.69

ug/l

0.26

116

(3006270) Folate [Moles/volume] in Blood

152

430

1.78

9.02

1.2

1.1

367.83

390.14

nmol/l

0.48

131

377

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

215

670

1.62

9.01

1.4

337.92

288.46

pmol/l

0.70

187

595

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

100

245

2.05

9.00

1.7

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

104

259

2.02

8.97

1.6

1.8

3.85

2.42

u/field

0.39

203

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.06

8.95

1.3

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

111

2.63

8.93

1.5

1.2

3.46

3.96

mmol/l

0.43

103

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

144

402

1.80

8.92

1.4

1.3

3.22

5.29

ug/l

1.03

128

327

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

173

2.27

8.91

1.1

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

134

367

1.84

8.82

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

125

335

1.88

8.79

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

121

2.53

8.79

1.2

27.29

17.50

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1957

8493

1.17

8.76

1.4

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

5.25

8.75

3.0

3.3

1.08

1.27

mg/l

0.18

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

181

2.22

8.74

1.1

1.0

245.26

238.57

ng/l

0.01

(40759836) Histone Ab [Presence] in Serum by Immunoblot

132

361

1.84

8.73

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

362

1.83

8.66

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

132

362

1.83

8.66

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

122

2.51

8.65

1.2

1.3

38.55

41.22

g/l

0.75

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

133

366

1.83

8.64

1.1

1.2

—

(3001556) Androgen free Index in Serum or Plasma

3.89

8.61

1.2

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

+∞

8.58

7.0

0.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

133

367

1.82

8.57

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

186

2.19

8.56

2.6

2.7

1.59

1.23

ug/l

0.48

173

(3036525) Urea [Moles/time] in 24 hour Urine

16.06

8.53

3.3

1.0

—

(3007463) Buprenorphine [Presence] in Urine

16.06

8.53

5.3

12.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

197

2.14

8.45

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.12

8.45

1.4

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

2.73

8.43

1.3

1.2

64.44

47.62

mu/l

0.35

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.80

8.36

9.5

5.4

0.31

0.24

umol/l

0.63

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

4.14

8.36

1.0

0.07

0.88

u/ml

0.47

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

148

426

1.75

8.33

5.6

5.1

42.04

125.58

u/ml

1.79

140

(3010144) Erythrocytes [#/volume] in Synovial fluid

179

545

1.65

8.25

1.4

1.3

128538.34

78638.58

e6/l

0.39

126

383

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

114

2.51

8.11

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

2.58

8.11

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

4.02

8.09

1.0

0.08

0.33

u/ml

0.64

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

4.02

8.09

1.0

1.2

0.68

3.22

u/ml

1.28

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.33

7.87

3.5

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

214

690

1.56

7.86

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

358

1282

1.41

7.85

1.1

6.85

6.26

u/ml

0.21

201

591

(3034426) Prothrombin time (PT)

157

2.24

7.85

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.06

7.83

1.2

1.1

1.53

1.64

mmol/l

0.19

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

197

2.09

7.82

1.1

1.0

10.78

4.74

u/ml

0.79

(3014891) Appearance of Pleural fluid

3.49

7.77

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.61

7.68

5.1

2.4

—

(4034850) Laboratory test

515

3357

0.76

7.66

10.3

7.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

391

1428

1.38

7.66

1.1

2.55

2.78

u/ml

0.15

213

629

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

103

272

1.90

7.63

1.6

1.5

6.57

4.84

u/l

0.59

207

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

143

2.28

7.62

1.1

1.0

16.52

11.18

u/ml

0.66

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

112

2.47

7.58

1.1

238.77

315.33

pmol/l

0.77

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

4.31

7.51

1.0

1.19

0.10

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

105

281

1.88

7.49

7.1

7.2

—

(3051593) INR in Capillary blood by Coagulation assay

194

2.07

7.47

13.5

12.2

—

(3024263) Appearance of Synovial fluid

101

267

1.90

7.47

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

110

2.47

7.45

1.8

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.91

7.44

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

215

2.01

7.42

1.8

1.4

1.60

6.34

nmol/l

1.30

181

(3012565) Volume of 24 hour Urine

103

275

1.88

7.40

2.6

2.0

1964.40

2153.37

1.00

247

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.22

7.39

1.8

1.5

14.67

60.11

pmol/l

1.48

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.05

7.31

1.2

1.0

—

(3008607) Semen analysis panel

3.55

7.22

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

1226

1.40

7.21

1.1

2.16

2.56

u/ml

0.32

188

519

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

314

1.81

7.20

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.83

7.11

1.1

77.67

85.59

0.20

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

205

2.01

7.10

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

176

556

1.59

7.09

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

113

316

1.80

7.07

1.1

1.2

1.06

1.09

ratio

0.66

122

(3002079) Sodium [Moles/time] in 24 hour Urine

238

1.92

6.97

1.4

1.2

180.14

181.15

mmol/24h

0.03

238

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

130

2.28

6.93

1.4

1.6

16.14

15.02

pmol/l

0.27

113

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.49

6.90

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

299

1063

1.42

6.89

1.2

—

(3047189) Immunofixation for 24 hour Urine

211

1.98

6.88

1.8

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

269

938

1.44

6.88

1.1

2.54

2.61

u/ml

0.05

111

578

(3008401) Mugwort IgE Ab [Units/volume] in Serum

346

1263

1.38

6.86

1.1

1.53

1.26

u/ml

0.21

160

470

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.75

6.79

1.1

81.54

91.44

0.35

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.89

6.71

1.1

1.3

1.89

1.65

umol/24h

0.64

(1002224) Polysomnography panel

863

3565

1.22

6.71

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

129

382

1.70

6.68

1.3

1.2

—

(3019977) pH of Arterial blood

107

302

1.78

6.53

2.6

2.5

7.42

0.11

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

3.01

6.52

1.2

1.0

3.02

8.51

pmol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.11

6.44

1.4

1.2

1.23

2.59

mmol/l

0.45

(3020491) Glucose [Moles/volume] in Blood

140

431

1.63

6.30

2.1

1.9

6.95

7.06

mmol/l

0.17

335

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

+∞

6.24

8.9

0.0

—

(40768793) Breast Pathology biopsy report

268

953

1.42

6.22

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.17

6.19

1.6

2.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

184

608

1.52

6.17

1.3

1.5

32.86

37.75

iu/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

131

2.19

6.14

1.8

2.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

217

1.90

6.13

3.5

2.2

86.28

106.67

au/ml

0.19

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.49

6.11

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.18

6.10

1.4

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.54

6.07

1.1

93.46

85.59

0.72

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.81

6.02

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

248

1.82

5.97

1.0

1.1

97.36

98.87

0.17

186

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.52

5.97

1.6

2.32

2.78

mg/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

209

1.90

5.92

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.74

5.91

1.1

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

7.53

5.91

1.1

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

101

2.34

5.89

1.1

7.72

0.85

u/ml

0.63

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.81

5.85

1.6

1.3

4.94

8.23

0.81

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.44

5.78

1.0

1.2

1.79

8.63

u/ml

1.03

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

231

1.83

5.63

2.6

1.5

403.16

304.15

ug/l

0.10

217

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

389

1496

1.31

5.57

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

190

1.90

5.47

2.8

3.0

29.43

28.90

umol/l

0.14

148

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.11

5.43

1.4

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

174

586

1.49

5.41

1.6

1.4

27.64

32.00

0.84

111

383

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.72

5.41

3.4

2.3

39.95

43.56

umol/l

0.35

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

4.11

5.40

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.11

5.40

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

106

2.23

5.33

1.4

1.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

1.46

1.37

mg/l

0.03

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

0.53

1.01

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

2.21

4.06

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

4.55

1.51

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

3.19

2.30

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

0.51

3.64

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

2.17

0.75

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

3.07

3.34

mg/l

0.04

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.27

5.32

1.6

1.53

1.70

mg/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

143

2.04

5.31

1.1

1.65

5.41

u/ml

0.45

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

103

2.24

5.31

1.2

86.06

277.05

ug/l

0.82

(3029075) Extractable nuclear Ab panel - Serum

133

2.08

5.29

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

11.05

5.29

1.2

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.04

5.25

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

2.51

5.25

2.8

2.9

2736.08

1527.11

u/l

0.26

(3009015) Lactate [Moles/volume] in Synovial fluid

3.30

5.25

1.2

1.3

6.14

5.14

mmol/l

0.30

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.55

5.25

3.1

1.9

21.16

30.13

mg/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.95

5.21

2.3

1.3

161.89

81.17

ng/l

1.88

(3050794) Legionella sp Ab [Presence] in Serum

2.95

5.21

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.71

5.19

2.0

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

114

2.16

5.19

1.2

1.3

35.92

31.67

nmol/l

0.33

106

(3013336) Amino acids [Identifier] in Serum or Plasma

8.61

5.16

4.7

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.45

5.13

1.3

1.2

16.33

211.00

titre

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.68

5.12

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

227

814

1.40

5.12

1.3

1.2

7.12

7.30

mmol/l

0.38

203

699

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

1.87

5.08

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.39

5.07

2.7

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.67

5.00

1.2

1.04

1.39

ml/s/173m2

0.70

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.43

4.89

1.1

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

258

1.71

4.85

4.0

2.8

8.15

8.87

mg/l

0.46

202

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1786

9956

0.89

4.69

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

4.68

1.0

0.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

10.04

4.67

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

111

350

1.59

4.67

1.1

8.76

8.36

iu/ml

0.05

110

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

213

1.77

4.62

2.2

1.9

9.43

9.59

mg/l

0.08

167

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

247

1.71

4.60

1.1

1.2

15.13

25.13

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

690

2902

1.20

4.59

1.8

1.4

5.31

3.31

mg/l

1.36

498

1956

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

149

1.92

4.52

1.4

1.3

31.00

40.03

0.98

104

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

197

1.79

4.45

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.56

4.42

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

142

481

1.48

4.38

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

106

2.09

4.34

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.37

4.34

1.5

1.4

0.35

0.45

ug/l

0.57

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.47

4.29

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.61

4.28

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.35

4.23

1.0

0.38

3.43

u/ml

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.91

4.20

1.2

1.0

22.93

22.87

u/l

0.00

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.51

4.15

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

263

1.64

4.13

1.6

1.4

5.32

4.30

0.16

(3020393) Adenovirus Ag [Presence] in Stool

3.04

4.10

1.3

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

151

1.86

4.10

1.2

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

5.48

4.01

1.0

175.00

50.67

pmol/l

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.35

3.92

5.7

3.7

49.46

34.20

ug/min

0.60

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

161

1.81

3.90

1.7

66.04

150.62

au/ml

—

(3017400) Magnesium [Moles/volume] in Urine

+∞

3.90

1.0

0.0

2.86

—

mmol/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.59

3.87

3.2

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

260

1001

1.31

3.84

1.5

1.4

226.43

124.19

pmol/l

0.90

255

984

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

234

890

1.32

3.77

1.0

0.42

0.50

u/ml

0.16

160

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.38

3.77

1.2

1.1

—

(3019174) dRVVT (LA screen)

2.87

3.76

1.2

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.78

3.74

1.2

733.37

276.15

mg/24h

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

7.53

3.74

1.0

—

(3022670) pH of Venous cord blood

7.53

3.74

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.51

3.73

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.26

3.72

1.8

1.3

0.20

0.17

nmol/l

0.10

(3008116) Ketones [Moles/volume] in Urine by Test strip

100

2.01

3.65

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.21

3.57

1.3

1.6

14.88

17.42

nmol/l

0.13

(3013637) Mi-2 Ab [Presence] in Serum

2.03

3.57

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.03

3.57

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.03

3.57

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.03

3.57

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.28

3.56

2.1

1.5

—

(3000285) Sodium [Moles/volume] in Blood

2.22

3.48

1.1

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.12

3.47

1.1

1.0

77.84

79.92

ug/l

0.11

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

315

1.52

3.34

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.46

3.32

3.0

3.2

0.48

0.38

u/field

0.28

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

108

1.91

3.28

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.09

3.25

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.32

3.23

1.3

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.32

3.23

1.7

1.5

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

3.44

3.19

1.9

1.5

1.58

3.58

0.78

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

5.65

3.19

1.1

1.0

7.93

9.29

mmol/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1.66

3.12

2.2

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1.66

3.12

2.2

2.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.01

3.07

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

3.05

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.87

3.04

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.11

3.04

3.1

2.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.45

3.04

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1196

6643

0.90

3.03

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.00

3.02

1.4

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.02

2.96

2.2

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

116

1.82

2.95

2.0

2.4

8.01

7.96

mmol/l

0.02

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.74

2.91

1.0

—

mmol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.67

2.87

1.5

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.23

2.87

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

499

0.65

2.86

1.8

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

103

1.85

2.84

2.8

3.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.18

2.83

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

222

1.56

2.83

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

207

1.58

2.78

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

333

1.45

2.78

1.4

1.2

420.62

393.27

u/l

0.07

317

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.39

2.77

1.1

0.02

0.05

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

270

1095

1.24

2.74

1.1

1.0

3.70

4.17

u/ml

0.20

142

461

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.68

2.73

1.2

1.1

99.86

109.82

ug/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

116

1.78

2.70

1.4

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.90

2.69

1.5

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

139

1.70

2.68

1.6

1.3

98.81

465.45

nmol/24h

0.84

139

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.17

2.66

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

372

1565

1.20

2.65

1.6

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

117

1.76

2.64

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

117

1.76

2.64

1.4

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.01

2.63

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.59

1.0

—

(3013762) Body weight Measured

4.11

2.56

1.0

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.14

2.53

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.08

2.47

9.7

8.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.25

2.45

7.2

2.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.25

2.45

1.4

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.12

2.39

1.4

1.3

29.31

22.76

0.30

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.15

2.36

1.4

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

331

1396

1.19

2.34

1.1

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.87

2.31

4.2

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

330

1394

1.19

2.30

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.01

2.29

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.02

2.28

1.4

1.2

2.13

1.50

—

(1617658) Protocol used for examination of sentinel lymph nodes

339

1.39

2.27

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

123

1.67

2.27

1.3

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.31

2.23

1.1

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.48

2.22

1.2

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

548

0.71

2.22

1.4

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.43

2.18

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

1.82

2.13

2.3

2.4

3.31

4.47

ug/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.09

2.12

1.3

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

248

1029

1.21

2.12

1.1

1.0

4.89

5.52

u/ml

0.22

110

375

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.65

2.11

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.30

2.09

1.4

1.2

309.06

299.06

umol/24h

0.08

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

203

1.48

2.06

1.3

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.15

2.05

1.4

1.1

15.61

17.36

u/l

0.08

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.15

2.05

1.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

2.01

0.0

1.0

—

164.18

—

(3006462) Nitrate [Presence] in Urine

251

1.42

1.97

2.9

2.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.35

1.96

1.0

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.30

1.90

2.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.30

1.90

1.0

2.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

130

1.58

1.89

1.4

1.3

8.10

6.93

mmol/l

0.69

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.51

1.87

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.63

1.86

1.5

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.05

1.85

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.51

1.84

1.3

1.1

1.94

2.63

mmol/24h

—

(3032641) Amino acids panel - Urine

5.02

1.82

1.8

1.0

—

(4281824) Cell count and differential, peritoneal fluid

142

567

1.26

1.78

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.74

1.76

1.8

1.6

1.70

2.03

ug/l

0.21

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.41

1.74

1.3

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

117

1.59

1.74

1.6

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

1.57

1.74

1.2

—

(44813793) Dust mix specific IgE antibody measurement

113

440

1.29

1.74

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.15

1.73

1.1

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.76

1.73

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.76

1.73

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.76

1.73

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.76

1.73

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.76

1.73

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.76

1.73

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.96

1.68

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.96

1.68

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.66

1.2

—

(3016135) IgD [Mass/volume] in Serum

4.18

1.62

1.0

36.84

35.25

mg/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.82

1.58

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.35

1.57

2.8

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

221

1.39

1.54

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

188

1.42

1.51

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.07

1.49

1.1

1.12

1.74

u/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.84

1.44

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.84

1.44

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.70

1.44

1.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.01

1.43

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.01

1.43

1.0

1.1

—

(40758358) Immune stain study

2.68

1.37

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.28

1.33

1.2

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.74

1.30

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.73

1.28

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

2.36

1.26

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

128

1.45

1.24

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

120

1.46

1.23

1.2

304.46

28.32

mg/l

0.87

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.79

1.13

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.94

1.13

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

222

1.31

1.11

1.2

1.4

57.21

57.03

0.01

193

(3035320) C reactive protein [Mass/volume] in Body fluid

113

469

1.21

1.11

2.4

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

753

3526

1.07

1.08

1.8

1.7

—

(3034614) HLA Ag [Interpretation]

2.51

0.99

1.3

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.07

0.99

2.0

2.6

—

(4212803) Bone marrow aspirate examination

1.64

0.99

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

396

1821

1.09

0.93

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

124

1.38

0.92

1.7

2.1

96.37

97.69

ng/l

0.02

(3035933) Granulocytes/100 leukocytes in Blood

225

1.27

0.91

1.3

1.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.78

0.84

1.0

—

(3024316) Viscosity of Plasma

1.78

0.84

1.3

1.9

1.31

1.86

mpas

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

115

667

0.86

0.78

1.3

1.2

1.51

1.53

g/l

0.26

115

667

(3007542) Rye IgE Ab [Units/volume] in Serum

1.79

0.78

1.2

1.0

0.27

0.23

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.85

0.74

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

111

483

1.15

0.72

1.1

1.52

2.60

u/ml

0.42

100

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

203

1.24

0.68

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.41

0.67

2.8

2.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.49

0.67

2.4

2.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

808

4251

0.95

0.66

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.75

0.65

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.67

0.64

1.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.63

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.61

0.62

1.1

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.88

0.61

1.3

1.2

503.70

530.36

nmol/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.88

0.61

1.0

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.36

0.61

9.6

5.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.37

0.60

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.54

0.59

1.3

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.62

0.59

1.1

1.0

0.29

0.12

u/ml

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.67

0.57

4.8

6.2

0.36

0.27

mmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

369

1737

1.07

0.56

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.60

0.50

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

100

447

1.12

0.49

1.1

1.0

2.94

0.65

u/ml

0.46

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.49

0.48

1.7

1.3

21.67

24.60

—

(3015183) Erythrocyte sedimentation rate

421

1.12

0.46

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

104

471

1.11

0.43

1.1

0.90

2.95

u/ml

0.55

117

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

1.57

0.42

1.2

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.27

0.42

1.1

1.2

19.49

20.35

mmol/l

0.34

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.35

1.3

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.41

0.33

1.3

1.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.35

0.32

1.1

1.4

0.82

0.62

umol/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.35

0.31

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

228

1088

1.05

0.29

1.5

1.3

215.86

186.93

pmol/l

0.32

228

1088

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.34

0.29

1.3

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.30

0.29

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.25

0.28

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

118

1.15

0.23

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.29

0.22

1.0

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.18

0.19

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

367

1885

0.98

0.15

3.6

2.6

27.13

27.72

mg/l

0.11

228

1212

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.15

0.14

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.19

0.13

3.5

4.7

—

(1761868) Lipid panel - Serum or Plasma

6521

32844

1.00

0.12

2.8

2.6

—

(3025130) Human papilloma virus identified in Specimen

131

637

1.03

0.11

1.9

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.19

0.10

11.8

9.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

499

2472

1.01

0.09

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.86

0.07

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.93

0.06

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

232

0.97

0.03

1.6

1.3

—

(3004959) Base excess in Arterial cord blood by calculation

0.93

0.02

1.0

—

-2.14

—

(3006598) pH of Arterial cord blood

0.93

0.02

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.03

0.00

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.00

0.00

1.1

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

126

1.00

0.00

6.4

6.3

—

(3001729) Color of Synovial fluid

0.99

0.00

1.2

1.7

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

0.92

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI – Factors influencing health status and contact with health services

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Factors influencing health status and contact with health services

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Factors influencing health status and contact with health services (Z21_FACTO_INFLUENCI_HEALTH_STATUS_CONTACT_W_HEALTH_SERVI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints